<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">iScience</journal-id><journal-id journal-id-type="iso-abbrev">iScience</journal-id><journal-title-group><journal-title>iScience</journal-title></journal-title-group><issn pub-type="epub">2589-0042</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9436768</article-id><article-id pub-id-type="pii">S2589-0042(22)01193-2</article-id><article-id pub-id-type="doi">10.1016/j.isci.2022.104921</article-id><article-id pub-id-type="publisher-id">104921</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Multi-omics characterization reveals the pathogenesis of liver focal nodular hyperplasia</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Liu</surname><given-names>Yuming</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">6</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Zhang</surname><given-names>Jinmai</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="fn1" ref-type="fn">6</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Wang</surname><given-names>Zhuo</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="fn1" ref-type="fn">6</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Ma</surname><given-names>Jiaqiang</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Wang</surname><given-names>Ke</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Rao</surname><given-names>Dongning</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au7"><name><surname>Zhang</surname><given-names>Mao</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au8"><name><surname>Lin</surname><given-names>Youpei</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au9"><name><surname>Wu</surname><given-names>Yingcheng</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au10"><name><surname>Yang</surname><given-names>Zijian</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au11"><name><surname>Dong</surname><given-names>Liangqing</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au12"><name><surname>Ding</surname><given-names>Zhenbin</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au13"><name><surname>Zhang</surname><given-names>Xiaoming</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au14"><name><surname>Fan</surname><given-names>Jia</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author" id="au15"><name><surname>Shi</surname><given-names>Yongyong</given-names></name><email>shiyongyong@gmail.com</email><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au16"><name><surname>Gao</surname><given-names>Qiang</given-names></name><email>gao.qiang@zs-hospital.sh.cn</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff4" ref-type="aff">4</xref><xref rid="aff5" ref-type="aff">5</xref><xref rid="fn2" ref-type="fn">7</xref><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><aff id="aff1"><label>1</label>Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai 200032, China</aff><aff id="aff2"><label>2</label>Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai 200030, China</aff><aff id="aff3"><label>3</label>Key Laboratory of Molecular Virology &#x00026; Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China</aff><aff id="aff4"><label>4</label>Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China</aff><aff id="aff5"><label>5</label>State Key Laboratory of Genetic Engineering, Fudan University, Shanghai 200433, China</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>shiyongyong@gmail.com</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author <email>gao.qiang@zs-hospital.sh.cn</email></corresp><fn id="fn1"><label>6</label><p id="ntpara0010">These authors contributed equally</p></fn><fn id="fn2"><label>7</label><p id="ntpara0015">Lead contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>11</day><month>8</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>16</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>11</day><month>8</month><year>2022</year></pub-date><volume>25</volume><issue>9</issue><elocation-id>104921</elocation-id><history><date date-type="received"><day>27</day><month>4</month><year>2022</year></date><date date-type="rev-recd"><day>17</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>8</day><month>8</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 The Authors</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>The molecular landscape and pathogenesis of focal nodular hyperplasia (FNH) have yet to be elucidated. We performed multi-omics approaches on FNH and paired normal liver tissues from 22 patients, followed by multi-level bioinformatic analyses and experimental validations. Generally, FNH had low mutation burden with low variant allele frequencies, and the mutation frequency significantly correlated with proliferation rate. Although no recurrently deleterious genomic events were found, some putative tumor suppressors or oncogenes were involved. Mutational signatures indicated potential impaired mismatch function and possible poison contact. Integrated analyses unveiled a group of FNH specific endothelial cells that uniquely expressed SOST and probably had strong interaction with fibroblasts through PDGFB/PDGFRB pathway to promote fibrosis. Notably, in one atypical FNH (patient No.11) with pronounced copy number variations, we observed a unique immune module. Most FNH are benign, but molecularly atypical FNH still exist; endothelial cell derived PDGFB probably promotes the fibrogenic process in FNH.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">FNHs are genetically stable, but high mutation cases exist</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">FNHs have unique transcriptomic modules, and they alter in atypical FNH</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">FNH has a unique type of SOST-expressing endothelial cells that may promote fibrosis</p></list-item></list></p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Hepatology</kwd><kwd>Genetics</kwd><kwd>Molecular biology</kwd><kwd>Omics</kwd><kwd>Transcriptomics</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: September 16, 2022</p></notes></front><body><sec id="sec1"><title>Introduction</title><p id="p0030">Liver focal nodular hyperplasia (FNH) ranks the second highest morbidity among benign hepatic tumors after hepatic hemangioma (<xref rid="bib62" ref-type="bibr">Nahm et&#x000a0;al., 2011</xref>). FNH is more prevalent in women than men, especially at childbearing age (<xref rid="bib53" ref-type="bibr">Luciani et&#x000a0;al., 2002</xref>; <xref rid="bib26" ref-type="bibr">EASL, 2016</xref>). Hitherto, surgical resection is the only standard curative treatment of FNH (<xref rid="bib40" ref-type="bibr">Koea and Yeong, 2014</xref>), and the surgical procedure will inevitably affect quality of life or even severe postoperative complications. However, if left untreated, the patients may worry about whether FNH could become cancerous, as well as its increasing size over time in some progressive cases (<xref rid="bib81" ref-type="bibr">Tajiri et&#x000a0;al., 2014</xref>; <xref rid="bib41" ref-type="bibr">Kudo et&#x000a0;al., 2008</xref>). Despite the common sense that FNH is a benign tumor with almost no malignant potential (<xref rid="bib62" ref-type="bibr">Nahm et&#x000a0;al., 2011</xref>), its spatial proximity to hepatocellular carcinoma (HCC) within the same patients (<xref rid="bib15" ref-type="bibr">Chen et&#x000a0;al., 2001</xref>; <xref rid="bib67" ref-type="bibr">Petsas et&#x000a0;al., 2006</xref>) and its occurrence linking to chemotherapy-induced liver damage are well documented (<xref rid="bib92" ref-type="bibr">Zhu et&#x000a0;al., 2021</xref>; <xref rid="bib83" ref-type="bibr">Torri et&#x000a0;al., 2021</xref>). Thus, exploring how FNH phenotypic heterogeneity is formed and changed over time may provide clinical insights for FNH and HCC diagnosis and treatment design.</p><p id="p0035">Morphologically, FNH is featured by vascular malformation, ductular overreaction, and fibrous infiltration. Previous studies of FNH mainly focus on single molecules that are cancer or angiogenesis related genes, such as the overexpression of GLUL affacting WNT/&#x003b2;-catenin pathway (<xref rid="bib70" ref-type="bibr">Rebouissou et&#x000a0;al., 2008</xref>), the maplike distribution of glutamine synthetase (<xref rid="bib7" ref-type="bibr">Bioulac Sage et&#x000a0;al., 2009</xref>), and the upregulation of angiopoietin-1 (<xref rid="bib30" ref-type="bibr">Gouw et&#x000a0;al., 2010</xref>) and CD34 (<xref rid="bib54" ref-type="bibr">Maillette DeBuy Wenniger et&#x000a0;al., 2010</xref>). However, because of hypothesis-based research design and limited molecular profiling methods, clinical concerns mentioned above are not well resolved. Therefore, a data-driven approach that utilizes the state-of-art big data to deduce the molecular features of FNH, their correlation with biological behavior and association with the clinical outcome may complement current understanding of FNH initiation and progression.</p><p id="p0040">Next-generation sequencing has recently been widely utilized to characterize morphologically normal tissues and benign tumors, unveiling their novel pathogenesis and molecular alterations (<xref rid="bib38" ref-type="bibr">Kakiuchi and Ogawa, 2021</xref>; <xref rid="bib84" ref-type="bibr">Tomasetti, 2019</xref>). The mutational landscape of the normal esophageal epithelium (<xref rid="bib16" ref-type="bibr">Colom et&#x000a0;al., 2020</xref>), liver (<xref rid="bib9" ref-type="bibr">Brunner et&#x000a0;al., 2019</xref>; <xref rid="bib93" ref-type="bibr">Zhu et&#x000a0;al., 2019</xref>), and gastrointestinal tract (<xref rid="bib52" ref-type="bibr">Li et&#x000a0;al., 2021</xref>; <xref rid="bib50" ref-type="bibr">Lee-Six et&#x000a0;al., 2019</xref>) have been established to illustrate the dynamic clonal expansion that provides survival advantage. Likewise, it has been revealed that renal angiomyolipoma harbors TSC2 mutations and copy-neutral loss of heterozygosity (<xref rid="bib35" ref-type="bibr">Idogawa et&#x000a0;al., 2020</xref>), and uterine leiomyoma carries chromothripsis that is associated with aggressive cancers (<xref rid="bib56" ref-type="bibr">Mehine et&#x000a0;al., 2013</xref>), indicating that &#x0201c;benign tumors&#x0201d; may not always be genetically &#x0201c;faithful&#x0201d;. As a comprehensive approach, multi-omics studies have uncovered the mystery from premalignant lesions to early stages of cancer, including pre-invasive lung cancer (<xref rid="bib82" ref-type="bibr">Teixeira et&#x000a0;al., 2019</xref>), familial adenomatous polyposis (<xref rid="bib51" ref-type="bibr">Li et&#x000a0;al., 2020</xref>), and hepatocarcinogenesis (<xref rid="bib37" ref-type="bibr">Jee et&#x000a0;al., 2019</xref>), which link genotype with phenotype, offering valuable evidence for precise medication.</p><p id="p0045">Herein, we applied whole exome sequencing (WES), bulk RNA sequencing (RNA-seq), and single-cell RNA sequencing (scRNA-seq) on 22 paired FNH and adjacent normal liver tissues (aNL), followed by multi-level validation. We discovered that most FNH were genetically stable with specific transcriptomic modules. Of importance, FNH specific SOST-expressing vascular endothelial cells (ECs) and PDGFRB<sup>+</sup> fibroblasts contributing to fibrogenesis in FNH were identified and validated. Surprisingly, some FNH that had atypical molecular characteristics were also identified. Overall, the integrated analyses performed in this study established the genetic and molecular landscape of FNH, and indicated preliminary clues for clinical decision making.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Patient clinical characteristics</title><p id="p0050">Clinical information of all 22 FNH patients was summarized in <xref rid="mmc2" ref-type="supplementary-material">Table&#x000a0;S1</xref>. Among them, 19 cases were used for WES and RNA-seq, and 3 cases were applied for scRNA-seq. Eleven male and eight female patients were included, with no one having background liver disease. 68.4% of patients were between 20 and 40 years old, and age was comparable between two genders. Likewise, tumor sizes between the two gender groups were not statistically different (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>A). None of the patients received any chemotherapy, radiotherapy, interventional therapy or drug therapy before surgery.</p><p id="p0055">Individually, P11 simultaneously suffered from HCC in right lobe and FNH in left lobe (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>B). Considering the genetic abnormality of FNH of P07 and P11 (described below), the morphological features of them were confirmed again. For P11, we stained GS, CK19, AFP and ki-67, and typical map-like GS distribution and bile duct hyperplasia were found (<xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S1</xref>C&#x02013;S1F). We next re-checked the hematoxylin-eosin staining image of FNH in P07 with the highest number of somatic mutations, where an FNH-typical central scar and bile duct hyperplasia were seen (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>G). All sequenced FNH samples had morphologically typical features with map-like GS distribution and bile duct hyperplasia.</p></sec><sec id="sec2.2"><title>Not all FNH show genomic integrity</title><p id="p0060">The mean coverage was 99.5 and 99.2% for FNH and aNL, respectively; the depth of WES reached 154&#x000a0;&#x000b1; 34X (mean&#x000a0;&#x000b1; SD) and 73&#x000a0;&#x000b1; 22X (mean&#x000a0;&#x000b1; SD) for FNH and aNL under mean coverage, respectively. In total, we identified 773 somatic exonic mutations among all 19 patients (<xref rid="mmc3" ref-type="supplementary-material">Table&#x000a0;S2</xref>). Of them, 694 mutations were single nucleotide variation (SNV), and the rest 79 mutations were insertion or deletion (Indel). The majority of mutations were missense mutations (473 in total, 61.1%), followed by synonymous mutations (181 in total, 23.4%), and each remaining type was less than 5% (34 nonsense mutations, 29 non-frameshift deletions, 28 frameshift deletions, 17 frameshift insertions, 5 non-frameshift insertions, 5 unknown and 1 nonstop mutation in total) (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A). The variant allele frequency (VAF) of FNH was 0.132&#x000a0;&#x000b1; 0.09 (mean&#x000a0;&#x000b1; SD), indicating that mutations were only prevalent in a small proportion of cells within FNH.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Mutational landscape of FNH</p><p>(A) The constitution of somatic mutations in FNH (n&#x000a0;= 19).</p><p>(B) Individual mutational information (upper: the number of nonsynonymous mutations; middle: genes involved in mutation; bottom: basic clinical information).</p><p>(C) dS/dN analysis of FNH, TCGA-HCC and TCGA-CCA.</p><p>(D) The correlation between MKI67 expression and the number of mutations of 19 FNH samples (Spearman&#x02019;s rank correlation coefficient).</p><p>(E) The ratio of six-type base substitutions. The line and box represent median and upper and lower quartiles, respectively.</p><p>(F) Mutational signatures of each FNH sample.</p><p>(G) Number of clones inferred from mutational data. Each dot represents mutations belonging to each inferred clone.</p><p>(H) CNVs of each FNH sample.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>.</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0065">The number of somatic mutations among patients varied significantly (2&#x02013;220 mutations per patient, median 13 per patient), with patient P07 carrying the largest number of mutations and P04 having the fewest mutations (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B upper and <xref rid="mmc3" ref-type="supplementary-material">Table&#x000a0;S2</xref>). A total of 50 mutations were randomly selected for Sanger validation, reaching a success rate of 88% (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>A and <xref rid="mmc4" ref-type="supplementary-material">Table&#x000a0;S3</xref>). We checked genes being repeatedly hit among patients, and the mutations that appeared in more than three patients, homozygous mutations, or multi-hit events among patients were not detected. However, some putative tumor suppressors or oncogenes were affected. Mutations of <italic>ARID1B</italic>, a probable tumor suppressor (<xref rid="bib43" ref-type="bibr">Khursheed et&#x000a0;al., 2013</xref>), were detected in patients P07 and P14. <italic>ARID1B</italic> mutation (chr6: 157,522,487, G&#x0003e;T, V1574F) in P07 was predicted to be deleterious by different canonical algorithms. Likewise, <italic>ARID1B</italic> mutation (chr6: 157,488,191, G&#x0003e;T, G953V) in P14 was also predicted deleterious. The mutations of <italic>MMP10</italic>, which functions as an oncogene (<xref rid="bib22" ref-type="bibr">Deraz et&#x000a0;al., 2011</xref>), were detected in patients P07 (chr11: 102,651,271, A&#x0003e;T, Y18N) and P16 (chr11: 102,650,265, G&#x0003e;A, P106L), and both mutations were predicted to cause functional damage (<xref rid="mmc3" ref-type="supplementary-material">Table&#x000a0;S2</xref>). Whether FNH shared the same driver mutations with HCC (<xref rid="bib9" ref-type="bibr">Brunner et&#x000a0;al., 2019</xref>; <xref rid="bib29" ref-type="bibr">Fujimoto et&#x000a0;al., 2012</xref>) was explored, and only <italic>IGSF10</italic> was found mutated in P11 but not functionally harmful. Then, the mutational profiles were compared among FNH, normal liver (<xref rid="bib87" ref-type="bibr">Wijewardhane et&#x000a0;al., 2021</xref>), cirrhotic liver (<xref rid="bib93" ref-type="bibr">Zhu et&#x000a0;al., 2019</xref>) and HCC (<xref rid="bib9" ref-type="bibr">Brunner et&#x000a0;al., 2019</xref>; <xref rid="bib29" ref-type="bibr">Fujimoto et&#x000a0;al., 2012</xref>), and FNH did not share any mutation with normal liver either, whereas FNH and cirrhotic liver only shared <italic>ARID1B</italic> mutation. Such recurrent mutations in cirrhotic liver, like ARID1A and ARID1B, are viewed to confer adaptive changes that promote fitness and regeneration in response to chronic damage, instead of malignant transformation (<xref rid="bib93" ref-type="bibr">Zhu et&#x000a0;al., 2019</xref>). Patient P11, who also suffered from HCC, and an elderly patient P10, harbored the second and the third highest number of mutations, indicating that mutations might preferably arise from diseased or aged liver. In addition, dS/dN (<xref rid="bib58" ref-type="bibr">Martincorena et&#x000a0;al., 2017</xref>) analysis was applied to FNH and TCGA hepatocellular carcinoma/cholangiocarcinoma (TCGA-HCC/CCA) datasets, and no positive mutational selection was found to present in FNH, whereas TCGA-HCC and TCGA-CCA both had positive selection (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C), supporting the notion that FNH did not harbor cancer driver mutations. Conclusively, despite that FNH was not driven by somatic gene mutations, high-mutation cases indeed exist, and some potential tumor suppressors and oncogenes were impaired and likely driving clonal expansion.</p><p id="p0070">Mutations often occur during cell proliferation and division (<xref rid="bib14" ref-type="bibr">Cairns, 1975</xref>). Thus, the relationship between the cell proliferation rate and the number of mutations was investigated. <italic>MKI67</italic> (gene encoding Ki-67) transcripts per million expression was explored as a cell proliferation marker, and a significant positive correlation between mutation load and <italic>MKI67</italic> expression level (r&#x000a0;= 0.50, p&#x000a0;= 0.03, <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>D) was identified. However, the correlation between <italic>MKI67</italic> expression and tumor size was not significant. This phenomenon indicates that mutations of FNH may have an intrinsic connection with cell proliferation, and close follow-up should be applied to FNH with high proliferative capability, regardless of tumor size. These results are consistent with the clinical observation that progressive FNH was not always large lesions (<xref rid="bib81" ref-type="bibr">Tajiri et&#x000a0;al., 2014</xref>; <xref rid="bib41" ref-type="bibr">Kudo et&#x000a0;al., 2008</xref>).</p><p id="p0075">The mutational spectrum and signatures of FNH were also explored. FNH had a nearly equal number of transition and transversion, where C to T was the predominant type of base substitution (&#x0003e;25% of total mutations), followed by C to A and T to C (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>E), which is similar to cirrhotic liver (<xref rid="bib93" ref-type="bibr">Zhu et&#x000a0;al., 2019</xref>). Of them, C to T and T to C were also the main mutational features of HCC and CCA (<xref rid="bib2" ref-type="bibr">Alexandrov et&#x000a0;al., 2013</xref>; <xref rid="bib23" ref-type="bibr">Dong et&#x000a0;al., 2018</xref>), indicating their commonality in liver tumors. The mutational pattern was deconstructed and compared to COSMIC signature database and signatures with weight &#x02265; 0.1 were thought significant (<xref rid="bib23" ref-type="bibr">Dong et&#x000a0;al., 2018</xref>). Liver cancers commonly show signature 16 (<xref rid="bib9" ref-type="bibr">Brunner et&#x000a0;al., 2019</xref>), and four FNH cases showed signature 16 as well. Poison contact (<xref rid="bib32" ref-type="bibr">Henry et&#x000a0;al., 1999</xref>) or defective DNA mismatch repair function can contribute to the pathogenesis of liver cancers (<xref rid="bib94" ref-type="bibr">Zekri et&#x000a0;al., 2005</xref>). Similarly, signatures 1, 22, and 24, which indicate potential exposure to poisons appeared in 8 of 19 FNH samples; four lesions showed signature 20 that implied defective DNA mismatch repair function. Nevertheless, different from cirrhotic liver and HCC (<xref rid="bib9" ref-type="bibr">Brunner et&#x000a0;al., 2019</xref>), FNH did not show signature 5, indicating that age may not dominantly account for mutational accumulation in FNH (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>F).</p><p id="p0080">The clonal status of FNH was deduced using VAF (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>G). Except for P04 having too few mutations, other samples were successfully analyzed for the number of clones. In total, 7 of the 18 FNH lesions were monoclonal, and the remaining 11 were polyclonal, which was consistent with a previous study that most FNH lesions were polyclonal origin (<xref rid="bib66" ref-type="bibr">Paradis et&#x000a0;al., 1997</xref>). In contrast, the monoclonal origin was well recognized in malignant tumors like HCC and CCA (<xref rid="bib13" ref-type="bibr">Cai et&#x000a0;al., 2009</xref>). Hence, we suspected that the monoclonal FNH of P11, which has the second highest mutational load and the highest proliferative rate, showed partial molecular features akin to HCC. Thus, AFP and Ki-67 were stained for this lesion. Enlarged nucleus, disappeared hepatic plates, and positive AFP or Ki-67 staining were observed in many cells within this case (<xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S1</xref>E andS1F), indicating pathologically cancer-like morphology.</p><p id="p0085">Tumor mutational burden (TMB) of FNH was compared to TCGA tumors, and its TMB ranked 32 in all 34 types of tumors (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>B). Among malignant tumors, kidney chromophobe, testicular germ cell tumors, uveal melanoma, acute myeloid leukemia and thyroid carcinoma did not show significantly different TMB with FNH. All TCGA benign tumors including thymoma and pheochromocytoma and paraganglioma did not show significantly different TMB with FNH as well. This result indicates that FNH has relatively low TMB, which is in agreement with its benign attribute. Each mutation was then substituted with its corresponding VAF, entitled VAF-TMB (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>C). Of interest, except for thyroid carcinoma, the other four malignancies mentioned above had significantly higher VAF-TMB than FNH, whereas there was no statistical difference in VAF-TMB between two benign tumors and FNH. Of interest, many of these features are also observed in liver cirrhosis (<xref rid="bib93" ref-type="bibr">Zhu et&#x000a0;al., 2019</xref>). When only considering VAF &#x0003e;5%, FNH had a mean of 10.9% and a median of 9.3% VAF (excluding P11), whereas cirrhotic liver has a mean of 10.5% and a median of 8.7% VAF, indicating that mutations may affect same proportion of cells in two diseases. These results again indicate that FNH, as a benign tumor, has fewer cells affected by mutations than malignant tumors.</p></sec><sec id="sec2.3"><title>Copy number variations of FNH</title><p id="p0090">Neither significantly recurrent arm-level copy number variations (CNVs), nor significantly recurrent focal level CNVs in FNH (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>H) were found. However, significant arm-level CNVs of P11 were detected in chromosomes 4q, 7q, 8p, 8q, 16q, and 17p, which were also commonly detected in HCC (<xref rid="bib68" ref-type="bibr">Qin et&#x000a0;al., 1999</xref>). CNVs were confirmed by inspecting the gene expression level in corresponding regions (<xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S2</xref>D). Tumor suppressor genes such as <italic>TP53</italic> and <italic>FAT4</italic> were included in these arm-level regions but no obvious downregulation of these genes was observed, possibly because the functions of these genes were compensated by another intact copy.</p><p id="p0095">The most prominent focal level CNV (copy number&#x000a0;= 3) was 113,640,020&#x02013;114353828 at 13q34 including <italic>TFDP1</italic> and <italic>CDC16</italic> with significant upregulation of their expression levels (<xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S2</xref>E and S2F). The copy number of <italic>TFDP1</italic> and <italic>CDC16</italic> at 13q34 was frequently amplified to enhance proliferative capability in HCC (<xref rid="bib90" ref-type="bibr">Yasui et&#x000a0;al., 2002</xref>). Altogether, although most of FNH samples did not exhibit common CNVs, P11 had already got features of HCC from both arm-level and focal level CNVs. However, we cannot conclude that FNH has the potential to undergo malignant transformation based on one case, and future integrative analysis enrolling more patients like P11 is needed.</p></sec><sec id="sec2.4"><title>Transcriptomic features of FNH</title><p id="p0100">Principal component analysis (PCA) of the transcriptomic profile revealed pronounced spatial distinction between FNH and aNL (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>A). Next, differentially expressed gene (DEG) analysis between FNH and aNL identified 589 significantly upregulated and 236 significantly downregulated genes. Among significantly upregulated genes, some fibrosis-related genes were found, such as <italic>PDGFB</italic>, <italic>PDGFRB</italic> (<xref rid="bib20" ref-type="bibr">Czochra et&#x000a0;al., 2006</xref>), <italic>CXCL6</italic> (<xref rid="bib18" ref-type="bibr">Cai et&#x000a0;al., 2018</xref>), <italic>NOTCH3</italic> (<xref rid="bib11" ref-type="bibr">Chen et&#x000a0;al., 2012</xref>), and <italic>COL1A1</italic> (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A). Functional enrichment analysis showed the significant upregulation of extracellular matrix (ECM) production and PI3K/AKT pathway (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B). Also, the PDGF pathway was significantly enriched, again implying its contribution to the fibroblastic process. Meanwhile, Ingenuity Pathway Analysis (IPA) unearthed possible cell types that were responsible for transcriptomic alterations. The most significant canonical pathways were hepatic stellate cell activation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>B) and PDGFB/PDGFRB axis was the only detected input signal for stellate cell activation in FNH (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>C). Thus, PDGFB/PDGFRB-PI3K/AKT was the most possible pathway that may cause fibrosis in FNH.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Transcriptomic features of FNH and co-analyzing with canonical database</p><p>(A) Volcano plot shows DEGs between FNH and aNL.</p><p>(B) Functional enrichment analysis of significantly upregulated genes in FNH.</p><p>(C) PCA of FNH, aNL, TCGA-HCC, TCGA-CCA and GTEx normal liver transcriptome.</p><p>(D) Consensus clustering of FNH, aNL, TCGA-HCC, TCGA-CCA and GTEx normal liver transcriptome (k&#x000a0;= 5). Red highlights the position of FNH P11.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>.</p></caption><graphic xlink:href="gr2"/></fig></p><p id="p0105">FNH transcriptome was compared with TCGA-HCC, TCGA-CCA and GTEx normal liver using PCA. As expected, FNH, aNL and GTEx normal liver were spatially adjacent, whereas TCGA-HCC and TCGA-CCA were located oppositely (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C). This result preliminarily indicates the benign attribute of FNH. Surprisingly, we found P11 was away from other FNH counterparts and spatially close to TCGA-HCC. Further, consensus clustering was utilized and five classes were confirmed referring to consensus cumulative distribution function (CDF) value (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D left and S3D). Similarly, FNH, aNL and GTEx normal liver were clustered together mostly in clusters 1 and 5, whereas TCGA-HCC was in clusters 2 or 3 and TCGA-CCA was in cluster 4. Once again, P11 was clustered in clusters 1, 2 and 3, which suggests its similarity to TCGA-HCC. As a comparison, aNL of P11 was still clustered in clusters 1 and 5 as other NLs (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D right).</p></sec><sec id="sec2.5"><title>FNH has specific transcriptomic modules</title><p id="p0110">The transcriptomic data of five types of samples (FNH, aNL, TCGA-HCC, TCGA-CCA and GTEx normal) were decomposed using independent component analysis (ICA). In total, 35 independent components (ICs) reached the stable status of the model followed by unsupervised clustering, and four modules were generated (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A). The point biserial correlation coefficients between meta-samples and binary vectors (e.g., all FNH samples were defined as 1 and other types of samples were defined as 0) were calculated as previously described (<xref rid="bib6" ref-type="bibr">Aynaud et&#x000a0;al., 2020</xref>). It is worth noting that IC13 and IC7 in modules 3 and 4, respectively, highly correlated with FNH and aNL, whereas ICs such as IC2, IC11, IC17 and IC29 in module 2 correlated with malignancies (<xref rid="fig3" ref-type="fig">Figures&#x000a0;3</xref>A and 3B).<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>FNH owing its specific transcriptomic components</p><p>(A) ICA decomposes 35 independent components from FNH, aNL, TCGA-HCC, TCGA-CCA and GTEx normal liver transcriptome. Unsupervised clustering generates 4 basic transcriptomic modules (Pearson correlation coefficient).</p><p>(B) IC7 and IC13 highly correlated with FNH or aNL (The point-biserial correlation coefficient).</p><p>(C) ssGSEA on IC13 depicting many features of FNH. NES, normalized enrichment score.</p><p>(D) Scoring each type of sample using ICs with biological significance (Mann&#x02013;Whitney U test). The line represents median. &#x02217;, p&#x000a0;&#x0003c;&#x000a0;0.05; &#x02217;&#x02217;, p&#x000a0;&#x0003c;&#x000a0;0.01; &#x02217;&#x02217;&#x02217;, p&#x000a0;&#x0003c;&#x000a0;0.001.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0115">Each IC was compared with BIODICA (<xref rid="bib10" ref-type="bibr">Captier et&#x000a0;al., 2022</xref>) (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>E) or MSigDB (<xref rid="bib46" ref-type="bibr">Liberzon et&#x000a0;al., 2011</xref>) database or manually annotated. Importantly, cellular senescence was most significantly enriched in IC13, which suggest an intact &#x0201c;brake&#x0201d; function in response to proliferation (<xref rid="bib12" ref-type="bibr">Campisi and D&#x02019;Adda, 2007</xref>). Other features such as CTNNB1 signature (<xref rid="bib70" ref-type="bibr">Rebouissou et&#x000a0;al., 2008</xref>), estrogen-related gene expression (<xref rid="bib1" ref-type="bibr">Aldinger, 1977</xref>) and NOTCH signaling in fibrogenesis (<xref rid="bib11" ref-type="bibr">Chen et&#x000a0;al., 2012</xref>) have been reported in FHN or liver fibrosis. Thus, IC13 was entitled FNH-like IC (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). Likewise, IC7 was abundant in macrophages and endothelial signatures, thus named FNH-Immune (<xref rid="mmc5" ref-type="supplementary-material">Table&#x000a0;S4</xref>).</p><p id="p0120">Next, each sample was scored using the leading genes in ICs that highly correlated with samples and had biological significance. As expected, FNH-Like score was significantly higher in FNH than in other types of samples, whereas the FNH-Immune score in FNH was significantly higher than other types of samples lower than aNL (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D). Other ICs also delineated other features of FNH, such as fibrosis, ECM generation, moderately elevated proliferative capacity and ductular proliferation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>F). Meanwhile, the FNH-Immune score of P11 FNH was significantly lower than P11 aNL, with significantly elevated proliferation score but FNH-Like score did not decrease. This result molecularly proved that lesion of P11 was FNH and further explained what alterations happened in P11 that made its transcriptome analogous to HCC mentioned above.</p></sec><sec id="sec2.6"><title>Single-cell landscape of FNH</title><p id="p0125">To further explore FNH molecular characteristics and pathogenesis, three freshly dissected paired FNH and aNL were dissociated into single cell suspension, followed by flow cytometry sorting living cells and scRNA-seq. In total, 54,221 cells (including 27,474 cells from FNH, 26,747 cells from aNL) passed quality control, with 27 clusters of cells generated and visualized by uniform manifold approximation and projection (UMAP) (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A). Each cluster was then annotated automatically and verified manually, resulting in 11 major cell types (<xref rid="fig4" ref-type="fig">Figures&#x000a0;4</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S4</xref>A).<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>The single cell landscape of FNH</p><p>(A) The single-cell landscape of FNH. 26 clusters were automatically generated under the resolution of 1.2.</p><p>(B) Annotations of cells in each cluster.</p><p>(C) Venn graph showing 145 intersected significantly upregulated genes in FNH between RNA-seq and pseudo-bulk DEG analysis.</p><p>(D) Pathway enrichment analysis for significantly upregulated genes in pseudo-bulk FNH samples.</p><p>(E) The proportion of different type of cells in FNH and aNL (paired FNH and aNL, n&#x000a0;= 3). Data are represented as mean&#x000a0;&#x000b1; SD.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>.</p></caption><graphic xlink:href="gr4"/></fig></p><p id="p0130">To evaluate whether the main features captured by scRNA-seq, three paired pseudo-bulk samples were generated using the scRNA-seq data, followed by DEG analysis. Among significantly upregulated genes in FNH detected by bulk RNA-seq and pseudo-bulk DEG analyses, 145 intersected genes were discovered (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>C). Many essential genes that related to FNH intrinsic features, such as <italic>CXCL6</italic>, <italic>PDGFB</italic>, <italic>PDGFRB</italic>, and <italic>NOTCH3</italic>, were all included. At single cell level, <italic>CXCL6</italic> was found mainly in hepatocytes, <italic>PDGFB</italic> in endothelial cells, <italic>PDGFRB</italic> and <italic>NOTCH3</italic> in fibroblasts (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>B), supporting the IPA results (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>C). Also, the pathways enriched in pseudo-bulk samples showed a high&#x000a0;degree of consistency with those in bulk analysis, again indicating the enhanced ECM interaction,&#x000a0;the possible involvement of PI3K-AKT signaling and underlying vascular changes in FNH (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>D).</p><p id="p0135">The proportions of each type of cells were next analyzed to explore FNH specific components (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>E). Because of the limited number of fibroblasts captured by scRNA-seq (577 cells from FNH and 20 cells from aNL), we were only able to analyze as a whole. Even so, ECM deposition related genes, such as <italic>COL4A1</italic> and <italic>COL4A2</italic>, were observed significantly upregulated in the fibroblasts of FNH compared to aNL. Many ECM formation or interaction pathways were enriched in the fibroblasts of FNH as well. FNH had significantly more endothelial cells compared to aNL, which was consistent with the pathological feature of vascular proliferation. Among immune cells, macrophages dominated FNH with an abundance of over 5%, which was proved by the deconvolution of bulk RNA-seq data. Importantly, FNH-Immune consisted of genes mostly representing macrophage, which conspicuously distinguished FNH from other types of samples. Therefore, macrophages and endothelial cells that were highly enriched in FNH were selected for further analysis.</p></sec><sec id="sec2.7"><title>Kupffer cells are abundant in FNH</title><p id="p0140">In total, 2,817 macrophages (1,987 from FNH and 830 from aNL) with three clusters were identified (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A). Macrophage cluster 1 (M&#x003c6;_1) expressed a high level of <italic>CD206</italic>, <italic>CD163</italic> and <italic>MARCO</italic>, showing the identity of the non-inflammatory Kupffer cell (<xref rid="bib55" ref-type="bibr">MacParland et&#x000a0;al., 2018</xref>). M&#x003c6;_2 highly expressed <italic>S100A8/9</italic> and <italic>EREG</italic> (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B), indicative of the role of pro-inflammation (<xref rid="bib55" ref-type="bibr">MacParland et&#x000a0;al., 2018</xref>; <xref rid="bib17" ref-type="bibr">Cao et&#x000a0;al., 2019</xref>). The proportion of M&#x003c6;_1 and M&#x003c6;_2 significantly differed between FNH and aNL, with FNH having more Kupffer cells whereas aNL owning more pro-inflammatory macrophages (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). Co-staining of CD68 and CD206 in additional six samples confirmed the results as well (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>D).<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>The features of macrophages in FNH</p><p>(A) UMAP showing three main types of macrophages in FNH.</p><p>(B) The marker genes of each clusters.</p><p>(C) The relative ratio of each type of macrophages in FNH and aNL.</p><p>(D) IHC confirming the constitutional differences of CD68<sup>+</sup>CD206<sup>+</sup> macrophages between FNH and aNL (paired FNH and aNL, n&#x000a0;= 6; Paired Student&#x02019;s <italic>t</italic> test).</p><p>(E) Single-cell data exhibiting a decrease of MARCO<sup>+</sup> macrophages in HCC.</p><p>(F) qRT-PCR data indicating the decreased level of MARCO in HCC (FNH, n&#x000a0;= 7; HCC, n&#x000a0;= 9; Mann-Whitney U test). The line and box represent median and upper and lower quartiles, respectively.</p><p>(G) IHC confirming significant fewer MARCO<sup>+</sup> macrophages in HCC of P11 and FNH of P11 compared to aNL of P11. &#x02217;,&#x000a0;p&#x000a0;&#x0003c;&#x000a0;0.05; &#x02217;&#x02217;, p&#x000a0;&#x0003c;&#x000a0;0.01; &#x02217;&#x02217;&#x02217;, p&#x000a0;&#x0003c;&#x000a0;0.001.</p></caption><graphic xlink:href="gr5"/></fig></p><p id="p0145">To further investigate the distribution of M&#x003c6;_1 MARCO<sup>+</sup> macrophages, the FNH scRNA-seq data from this study were combined with scRNA-seq from an in-house HCC dataset and a normal liver dataset in a previous study (<xref rid="bib55" ref-type="bibr">MacParland et&#x000a0;al., 2018</xref>). MARCO was hardly detectable in macrophages from HCC, consistent with the previous study (<xref rid="bib75" ref-type="bibr">Sun et&#x000a0;al., 2017</xref>), whereas it showed a relatively high expression in normal liver datasets, FNH and aNL (<xref rid="fig5" ref-type="fig">Figures&#x000a0;5</xref>E and 5F). Of note, in P11, FNH rather than corresponding aNL, showed a nearly negative signal of MARCO, similar to that in HCC, whereas the remaining 18 FNH and paired aNL showed obvious staining of MARCO (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>G). Clinically, superparamagnetic iron oxide contrast is able to be taken by Kupffer cells in liver, thus Kupffer-cell-poor lesions can be differentiated (<xref rid="bib79" ref-type="bibr">Tanaka et&#x000a0;al., 1996</xref>). Therefore, superparamagnetic iron oxide MR contrast may be used to monitor potential molecular transformation based on the abundance of Kupffer cells in certain FNH non-invasively.</p></sec><sec id="sec2.8"><title>FNH had a unique type of SOST<sup>+</sup> endothelial cells</title><p id="p0150">Previous morphological studies assumed that abnormal blood flow might fuel hyperplasia (<xref rid="bib70" ref-type="bibr">Rebouissou et&#x000a0;al., 2008</xref>), driving us to further ask whether FNH had unique endothelial features. A total of 4,194 endothelial cells (3,561 from FNH and 633 from aNL) were identified with 10 clusters generated (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A). All ECs cells of FNH and aNL detected were positive for vascular markers <italic>PECAM1</italic> (CD31) and <italic>FLT1</italic> (<xref rid="bib31" ref-type="bibr">Hirakawa et&#x000a0;al., 2003</xref>) but negative for lymphatic EC marker <italic>PDPN</italic> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>A) (<xref rid="bib3" ref-type="bibr">Amatschek et&#x000a0;al., 2007</xref>).<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>ECs of FNH probably promoting fibrogenesis and showing an SOST<sup>+</sup> subtype</p><p>(A) The landscape of ECs in FNH.</p><p>(B) Ratios of all EC clusters in FNH and aNL. # and &#x02217; denotes cluster 4 and 6, respectively.</p><p>(C) DEGs between ECs of FNH and aNL at single cell level.</p><p>(D) RNA ISH proving the expression of SOST in ECs of blood vessels in fibrous septa in FNH but not in any structure of aNL.</p><p>(E) Functional enrichment analysis of significantly upregulated genes of ECs in FNH.</p><p>(F) Cell-cell interaction analysis indicating ECs in cluster 6 having the strongest interaction with fibroblasts.</p><p>(G) Representative mIF showing PDGF-B<sup>high</sup> vascular ECs are spatially adjacent to PDGFRB<sup>+</sup> fibroblasts in fibrous septa of FNH; whereas no PDGFB<sup>high</sup> ECs in aNL nor PDGFRB<sup>+</sup> fibroblasts closely around vascular ECs in aNL. Scale bar, 50&#x003bc;m. A, artery; B, bile duct; V, vein.</p><p>See also <xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S5&#x02013;S7</xref>.</p></caption><graphic xlink:href="gr6"/></fig></p><p id="p0155">We next explored FNH-enriched endothelial clusters and their specific genes. Compared to aNL, the most prominent differences concentrated on cluster 4 and cluster 6 (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B) that expressed both venous marker <italic>COUP-TFII</italic> and arterial marker <italic>DLL4</italic> but negative for sinus marker <italic>MRC1</italic> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>B) (<xref rid="bib24" ref-type="bibr">deHaan et&#x000a0;al., 2020</xref>; <xref rid="bib25" ref-type="bibr">Diez et&#x000a0;al., 2007</xref>), indicating an ambiguous status between artery and vein. DEG analysis was performed between all ECs of FNH and aNL. The most upregulated genes (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C), such as <italic>COL4A1</italic>, <italic>SOST</italic>, <italic>EDNRB</italic>, were mostly expressed in clusters 4 and 6 (<xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S5</xref>C&#x02013;S5E). The expression of COL4A1 indicates an increased activity in ECM production and high <italic>EDNRB</italic> expression on ECs indicates an enhanced ability of proliferation and migration (<xref rid="bib95" ref-type="bibr">Ziche et&#x000a0;al., 1995</xref>). <italic>SELE</italic>, found in activated or proliferating endothelial cells (<xref rid="bib63" ref-type="bibr">Nishiwaki et&#x000a0;al., 2007</xref>), was the gene with the highest fold change and its distribution was relatively equal among clusters (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>F), indicating the diffusive molecular alterations in ECs of FNH. Then, the relationship between endothelial clusters was inferred using pseudo-trajectory analysis. Surprisingly, cluster 6 with <italic>SOST</italic> expression was mostly located at the middle and generated a new branch, whereas all ECs from aNL were found at the ends of the trajectory (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>G). The result indicates that FNH had a unique type of ECs expressing <italic>SOST</italic>, independent of any ECs in aNL. To corroborate that SOST<sup>+</sup> ECs were FNH specific, the intersection of FNH upregulated genes in RNA-seq, scRNA-seq and marker genes of cluster 6 were acquired, and <italic>SOST</italic> was within it (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>A). Moreover, other types of liver samples, including fetal liver, normal liver, cirrhotic liver, HCC and CCA, were all negative for <italic>SOST</italic> expression (<xref rid="mmc1" ref-type="supplementary-material">Figures&#x000a0;S6</xref>B&#x02013;S6F). The expression of <italic>SOST</italic> in vascular ECs in fibrous septa of FNH but not in aNL was further confirmed by RNA <italic>in situ</italic> hybridization (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D).</p><p id="p0160">The functional enrichment analysis was performed at the whole EC level between FNH and aNL. The ECs of FNH showed significant enrichment of ECM associated pathways, PDGFBR signaling pathway and fluid shear stress pathway. Then, we re-analyzed the data excluding clusters 4 and 6, finding that ECM associated and PDGFBR signaling pathways were not enriched any more whereas fluid shear pathway was still enriched (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E). This result indicates that ECs of FNH may be broadly influenced by abnormal blood flow, and FNH specific ECs of clusters 4 and 6 are probably the main contributors of ECM deposition. In addition, cluster 4 exhibited a stronger function of vasculogenesis, whereas cluster 6 was more active in PDGFRB signaling, but the crosstalk between ECs and immune cells decreased (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>G). Moreover, metabolic signature analysis figured out that cluster 6 had stronger oxidative phosphorylation, citric acid cycle and glutathione metabolism but lower arginine metabolism, which suggests a more active functional and metabolic status but impaired endothelial protection function (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>H) (<xref rid="bib96" ref-type="bibr">Zhang et&#x000a0;al., 2006</xref>; <xref rid="bib65" ref-type="bibr">Prasad et&#x000a0;al., 1999</xref>; <xref rid="bib36" ref-type="bibr">Jongkind et&#x000a0;al., 1989</xref>). Together, FNH had a specific type of SOST<sup>+</sup> vascular ECs with higher ECM related activity and higher metabolic activity.</p><p id="p0165">Considering the involvement of PDGFRB signaling in FNH specific ECs, cell-cell interaction analysis was then performed. There were six clusters of ECs showing interaction with PDGFRB<sup>+</sup> fibroblasts, among which cluster 6 had the strongest interaction (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>F). Next, multiplex immunostaining of PDGFB, PDGFRB, &#x003b1;SMA, and CD31 in four paired FNH and aNL showed strong PDGFB intensity in vascular ECs from FNH instead of aNL. Correspondingly, PDGFRB<sup>+</sup> fibroblasts were found spatially proximal to PDGFB<sup>+</sup> ECs in FNH but not in aNL as well (<xref rid="fig6" ref-type="fig">Figures&#x000a0;6</xref>G and <xref rid="mmc1" ref-type="supplementary-material">S7</xref>A&#x02013;S7C), highlighting that PDGFB<sup>+</sup> ECs could activate fibroblast and promote fibrosis through spatially proximal PDGFB/PDGFRB pair (<xref rid="bib20" ref-type="bibr">Czochra et&#x000a0;al., 2006</xref>). In addition, the two cells within 4&#x000a0;&#x003bc;m were thought actively interacted (<xref rid="bib74" ref-type="bibr">Sheng et&#x000a0;al., 2021</xref>). Therefore, ECs within FNH may promote fibrosis through upregulating ECM pathways and activating fibroblasts by producing PDGFB.</p></sec></sec><sec id="sec3"><title>Discussion</title><p id="p0170">FNH is the second most common benign hepatic tumor, the prevalence of which is reported between 0.4 and 3% (<xref rid="bib54" ref-type="bibr">Maillette DeBuy Wenniger et&#x000a0;al., 2010</xref>). Transcriptomic signature related to FNH pathogenesis has been reported (<xref rid="bib70" ref-type="bibr">Rebouissou et&#x000a0;al., 2008</xref>), but the existence and relevance of the genomic and micro-environmental alterations remain less clear. Herein, we delineated the multi-omics characteristics of FNH in the scope of genome, transcriptome and single cell transcriptome and revealed that, despite mutations in tumor suppressors or oncogenes, FNH possesses a relatively stable genome with specific transcriptomic features. Combined with single cell data, we found FNH harbored abundant MARCO<sup>+</sup> Kupffer cells and a unique type of SOST<sup>+</sup> ECs that may contribute to the fibrotic process through PDGFB/PDGFRB axis. Interestingly, an atypical FNH was identified that gained an extra copy of 13q34 and excessive proliferative ability. Our work advanced the comprehensive understanding of FNH, which may further improve the clinical management of FNH.</p><p id="p0175">We observed no cancer driver events in FNH at genomic level, which is consistent with the previously reported results that the well-known driver genes in HCC do not appear in FNH (<xref rid="bib13" ref-type="bibr">Cai et&#x000a0;al., 2009</xref>). However, lesions with a high number of mutations and high proliferative rate were discovered. Despite that only passenger mutations were found, the mutational signatures still indicated impaired DNA repair functions in FNH. Though the mutational profiles between FNH and liver cirrhosis are generally different, FNH indeed shares some genomic features with liver cirrhosis (<xref rid="bib93" ref-type="bibr">Zhu et&#x000a0;al., 2019</xref>), indicating that genomic events are confined to a fraction of hepatocytes restricted by hyperplastic nodes. Thus, we recommended that FNH especially atypical FNH with a high proliferative rate should undergo surgical resection in time, and proliferation markers such as ki-67 should be stained routinely.</p><p id="p0180">Our RNA-seq and scRNA-seq data ascertain the fibrogenic nature of FNH, in agreement with its morphological feature (<xref rid="bib70" ref-type="bibr">Rebouissou et&#x000a0;al., 2008</xref>). We also revealed that EC-fibroblast interaction may be driven by PDGFB/PDGFRB interaction through PI3K-AKT pathway. One mechanism for fibrosis in FNH can be summarized as ECs that under abnormal blood flow secretes PDGFB, by which ECs activate and recruit hepatic stellate cells to form fibroblasts, and further <italic>in&#x000a0;vivo</italic> study is needed for validation. Notably, PDGFB/PDGFRB-PI3K/AKT was the only enriched pathway in FNH instead of famous TFGB1/TGFBR1 signaling, which differs from corresponding pathways reported in hepatitis-B-related liver fibrosis or alcohol-associated liver cirrhosis (<xref rid="bib42" ref-type="bibr">Kisseleva and Brenner, 2021</xref>). As for the source of fibroblasts, other than stellate cell formed fibroblasts, portal fibroblasts are another possible source of ECM producing myofibroblast. However, portal fibroblasts cannot be driven by PDGF (<xref rid="bib42" ref-type="bibr">Kisseleva and Brenner, 2021</xref>; <xref rid="bib89" ref-type="bibr">Wells et&#x000a0;al., 2004</xref>). These differences suggest the driving factor of FNH is different from those hepatocyte-injured diseases.</p><p id="p0185">Interestingly, FNH specific ECs of cluster 6, showing the strongest interaction with fibroblasts, also uniquely express <italic>SOST</italic>. <italic>SOST</italic> was initially discovered in bone and elevated while encountering mechanical stimulation (<xref rid="bib69" ref-type="bibr">Robling et&#x000a0;al., 2008</xref>). Studies about <italic>SOST</italic> and ECs are scarce. So far as we know, only one study reported that sclerostin increased the proliferation of human umbilical vein ECs <italic>in&#x000a0;vitro</italic> (<xref rid="bib64" ref-type="bibr">Oranger et&#x000a0;al., 2016</xref>). Nevertheless, which factors drive the expression of <italic>SOST</italic> in FNH and what is the exact biological significance are still elusive.</p><p id="p0190">P11 is the most special among all samples sequenced. FNH of P11 has the second largest number of mutations that were monoclonal origin, but there are no noxious mutations in famous oncogenes or tumor suppressors. However, CNVs in FNH of P11 suggests the similarity to early HCC. FNH of P11 preserves the main transcriptomic feature, but acquires extra proliferative capability. Essentially, MARCO<sup>+</sup> macrophages decreasing is the main immune alteration in P11. Thus, Kupffer cell sensitive contrast agent may help non-invasively trace FNH or alarm atypical FNH. However, further in-depth studies are needed to confirm this conclusion.</p><p id="p0195">In conclusion, by integrating WES, RNA-seq and scRNA-seq data, we revealed that most FNH are genetically stable but some molecularly atypical FNH still exist, discovered a new type of FNH specific ECs, and offered a probable mechanism of fibrogenesis in FNH. Our work advances the understanding of molecular pathogenesis of FNH and provides clues for clinical management.</p><sec id="sec3.1"><title>Limitations of the study</title><p id="p0200">Limitations of this study included the lack of cellular or animal models, which handicaps the study of mechanisms. Although WES yielded an average of 13% VAF mutations in FNH, it was possible that considerable somatic mutations with less VAF were left undetected. Ultra-high sequencing depth or single cell genome sequencing may better help reveal those hidden but important secrets.</p></sec></sec><sec id="sec4"><title>STAR&#x02605;Methods</title><sec id="sec4.1"><title>Key resources table</title><p id="p0205">
<table-wrap position="float" id="undtbl1"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>CD68</td><td>abcam</td><td>Cat# ab213363</td></tr><tr><td>CD206</td><td>abnova</td><td>Cat# 5C11</td></tr><tr><td>MARCO</td><td>ATLAS ANTIBODIES</td><td>Cat# HPA063793</td></tr><tr><td>PDGFRB</td><td>abcam</td><td>Cat# ab32570</td></tr><tr><td>PDGFB</td><td>abcam</td><td>Cat# ab23914</td></tr><tr><td>&#x003b1;SMA</td><td>abcam</td><td>Cat# ab5694</td></tr><tr><td>CD31</td><td>abcam</td><td>Cat# ab76533</td></tr><tr><td>GS</td><td>abcam</td><td>Cat# ab176562</td></tr><tr><td>CK19</td><td>abcam</td><td>Cat# ab52625</td></tr><tr><td>Ki-67</td><td>abcam</td><td>Cat# ab15580</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, peptides, and recombinant proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>DMEM, without glucose, L-glutamine, phenol red, sodium pyruvate and sodium bicarbonate</td><td>Sigma-Aldrich</td><td>Cat#D5030</td></tr><tr><td>Fetal Bovine Serum</td><td>Gibco</td><td>Cat# 10099141</td></tr><tr><td>Opal&#x02122; 7-Color Manual IHC Kit 50 slides</td><td>PerkinElmer</td><td>NEL811001KT</td></tr><tr><td>Collagenase IV</td><td>Gibco</td><td>Cat# 17104019</td></tr><tr><td>Dispase II</td><td>Gibco</td><td>Cat# 17105041</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Critical commercial assays</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>RNAscope&#x000ae; 2.5 HD Assay - Brown</td><td>Advanced Cell Diagnostics</td><td>Cat#322300</td></tr><tr><td>RNAscope&#x000ae; SOST Probes</td><td>Advanced Cell Diagnostics</td><td>Cat# 452941</td></tr><tr><td>RNAprep Pure Tissue Kit</td><td>TIANGENE</td><td>Cat#DP431</td></tr><tr><td>NEBNext&#x000ae; Ultra&#x02122; II Directional RNA Library Prep Kit</td><td>New England BioLabs</td><td>Cat#E7765</td></tr><tr><td>TIANamp Genomic DNA kit</td><td>TIANGEN</td><td>Cat#DP130227</td></tr><tr><td>Agilent SureSelect XT Human All Exon V5 kit</td><td>Agilent</td><td>Cat#5190-6213</td></tr><tr><td>Chromium Single Cell 3&#x02032; Reagent Kits</td><td>10&#x000d7; Genomics</td><td>Cat# PN-1000057</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Deposited data</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Normal liver single cell data</td><td>(<xref rid="bib102" ref-type="bibr">Aizarani et al., 2019</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE124395" id="intref0015">GSE124395</ext-link></td></tr><tr><td>Normal liver single cell data</td><td><xref rid="bib55" ref-type="bibr">MacParland et&#x000a0;al., 2018</xref></td><td><ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE115469" id="intref0020">GSE115469</ext-link></td></tr><tr><td>Liver cirrhosis single cell data</td><td>(<xref rid="bib101" ref-type="bibr">Ramachandran et al., 2019</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE136103" id="intref0025">GSE136103</ext-link></td></tr><tr><td>HCC and fetal liver single cell data</td><td>(<xref rid="bib99" ref-type="bibr">Sharma et al., 2020</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE156625" id="intref0030">GSE156625</ext-link></td></tr><tr><td>Intrahepatic CCA single cell data</td><td>(<xref rid="bib98" ref-type="bibr">Zhang et al., 2020</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE138709" id="intref0035">GSE138709</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Oligonucleotides</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Primers for Sanger sequencing, see <xref rid="mmc4" ref-type="supplementary-material">Table&#x000a0;S3</xref></td><td>This paper</td><td>N/A</td></tr><tr><td>Primer for SOST<break/>Forward: CGTCAGGATTGTCGGCAGTA<break/>Reverse: CCTTTGGAGTAACCCAGCAT</td><td>This paper</td><td>N/A</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>R V3.6.2</td><td>R Core Team</td><td><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/" id="intref0040">https://www.r-project.org/</ext-link></td></tr><tr><td>GraphPad Prism V8.0</td><td>GraphPad Software Inc</td><td><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism" id="intref0045">https://www.graphpad.com/scientific-software/prism</ext-link></td></tr><tr><td>Burrows- Wheeler Alignment V0.7.12</td><td><xref rid="bib48" ref-type="bibr">Li and Durbin, 2010</xref></td><td><ext-link ext-link-type="uri" xlink:href="http://bio-bwa.sourceforge.net/" id="intref0050">http://bio-bwa.sourceforge.net/</ext-link></td></tr><tr><td>FastQC V0.11.8</td><td>Babraham Bioinformatics</td><td><ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/" id="intref0055">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></td></tr><tr><td>Samtools V0.1.19</td><td><xref rid="bib21" ref-type="bibr">Danecek et&#x000a0;al., 2021</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/samtools/samtools" id="intref0060">https://github.com/samtools/samtools</ext-link></td></tr><tr><td>Mutect2</td><td>Broad Institute</td><td><ext-link ext-link-type="uri" xlink:href="https://gatk.broadinstitute.org/hc/en-us/articles/360037593851-Mutect2" id="intref0065">https://gatk.broadinstitute.org/hc/en-us/articles/360037593851-Mutect2</ext-link></td></tr><tr><td>CNVkit V0.9.5</td><td><xref rid="bib80" ref-type="bibr">Talevich et&#x000a0;al., 2016</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://cnvkit.readthedocs.io/en/stable/" id="intref0070">https://cnvkit.readthedocs.io/en/stable/</ext-link></td></tr><tr><td>dNdScv</td><td><xref rid="bib58" ref-type="bibr">Martincorena et&#x000a0;al., 2017</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/im3sanger/dndscv" id="intref0075">https://github.com/im3sanger/dndscv</ext-link></td></tr><tr><td>Maftools V3.1</td><td><xref rid="bib59" ref-type="bibr">Mayakonda et&#x000a0;al., 2018</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/maftools.html" id="intref0080">https://www.bioconductor.org/packages/release/bioc/html/maftools.html</ext-link></td></tr><tr><td>TopHat2 V2.1.1</td><td>(<xref rid="bib44" ref-type="bibr">Kim et al., 2019</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="http://ccb.jhu.edu/software/tophat/index.shtml" id="intref0085">http://ccb.jhu.edu/software/tophat/index.shtml</ext-link></td></tr><tr><td>Cufflinks V2.1.1</td><td>(<xref rid="bib100" ref-type="bibr">Trapnell et al., 2012</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="http://cole-trapnell-lab.github.io/cufflinks/" id="intref0090">http://cole-trapnell-lab.github.io/cufflinks/</ext-link></td></tr><tr><td>DESeq2 V1.14.1</td><td><xref rid="bib49" ref-type="bibr">Love et&#x000a0;al., 2014</xref></td><td><ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/release/bioc/html/DESeq2.html" id="intref0095">http://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td></tr><tr><td>edgeR V3.12</td><td>(<xref rid="bib72" ref-type="bibr">Robinson et al., 2009</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/edgeR.html" id="intref0100">https://bioconductor.org/packages/release/bioc/html/edgeR.html</ext-link></td></tr><tr><td>ggplot2 V3.3.0</td><td>(<xref rid="bib88" ref-type="bibr">Wickham, 2011</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggplot2/index.html" id="intref0110">https://cran.r-project.org/web/packages/ggplot2/index.html</ext-link></td></tr><tr><td>Biodica</td><td>Captier N et&#x000a0;al.</td><td><ext-link ext-link-type="uri" xlink:href="https://github.com/LabBandSB/BIODICA" id="intref0115">https://github.com/LabBandSB/BIODICA</ext-link></td></tr><tr><td>Consensusclusterplus V1.5</td><td>(<xref rid="bib86" ref-type="bibr">Wilkerson and Ayes, 2010</xref>)</td><td><ext-link ext-link-type="uri" xlink:href="http://bioconductor.org/packages/release/bioc/html/ConsensusClusterPlus.html" id="intref0120">http://bioconductor.org/packages/release/bioc/html/ConsensusClusterPlus.html</ext-link></td></tr><tr><td>Cellranger V3.1</td><td>10x Genomics</td><td><ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger" id="intref0125">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger</ext-link></td></tr><tr><td>Seurat V3.1.4</td><td><xref rid="bib76" ref-type="bibr">Stuart et&#x000a0;al., 2019</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/Seurat/index.html" id="intref0130">https://cran.r-project.org/web/packages/Seurat/index.html</ext-link></td></tr><tr><td>Monocle V2.1.4</td><td>Trapnell lab</td><td><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/monocle.html" id="intref0135">https://www.bioconductor.org/packages/release/bioc/html/monocle.html</ext-link></td></tr><tr><td>Cibersortx</td><td><xref rid="bib61" ref-type="bibr">Newman et&#x000a0;al., 2019</xref></td><td><ext-link ext-link-type="uri" xlink:href="https://cibersortx.stanford.edu/" id="intref0140">https://cibersortx.stanford.edu/</ext-link></td></tr><tr><td>ggsci V2.9</td><td>Xiao and Li</td><td><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=ggsci" id="PC_linkHSr10c5mrC">https://CRAN.R-project.org/package=ggsci</ext-link></td></tr></tbody></table></table-wrap>
</p></sec><sec id="sec4.2"><title>Resource availability</title><sec id="sec4.2.1"><title>Lead contact</title><p id="p0210">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Prof. Qiang Gao (<ext-link ext-link-type="uri" xlink:href="mailto:gao.qiang@zs-hospital.sh.cn" id="intref0150">gao.qiang@zs-hospital.sh.cn</ext-link>).</p></sec><sec id="sec4.2.2"><title>Materials availability</title><p id="p0215">This study did not generate new unique reagents.</p></sec></sec><sec id="sec4.3"><title>Experimental model and subject details</title><sec id="sec4.3.1"><title>Clinical sample acquisition</title><p id="p0220">19 Paired FNH and aNL samples for WES and RNA-seq were all acquired from patients underwent curative resection from January 2012 to December 2013 at Zhongshan Hospital. Three paired FNH and aNL samples for scRNA-seq were from December 2019 to January 2020 at Zhongshan Hospital. Samples of Hematoxylin-Eosin staining, IHC, fluorescent immunostaining and qRT-PCR were included in the 19 sample cohorts. Patients for ISH were from February 2021. The study was approved by the Research Ethics Committee of Zhongshan Hospital, and written informed consent was obtained from each patient.</p></sec></sec><sec id="sec4.4"><title>Method details</title><sec id="sec4.4.1"><title>Specimens processing</title><p id="p0225">After resected, paired FNH and aNL for sequencing were transferred in 10% FBS (Giboco, USA) RPMI-1640 medium (Sigma-Aldrich, USA), followed by washing for three times by PBS solution and visibly necrotic and hemorrhagic parts were carefully removed. Then, the clean samples were put into liquid nitrogen for snap frozen and stored in &#x02212;80&#x000b0;C for further processing. The time from sample collection to storage at &#x02212;80&#x000b0;C was strictly controlled within 30&#x000a0;minutes. aNL was used for germline analysis. All surgically resected samples were macroscopically and microscopically diagnosed by two experienced pathologists to assure FNH diagnosis.</p></sec><sec id="sec4.4.2"><title>DNA extraction, library construction, WES and sanger validation</title><p id="p0230">TIANamp Genomic DNA kit (TIANGEN, Beijing, China) standard procedure was applied to extract tissue DNA. Quality control was measured by Nanodrop 2000, and DNA content per sample &#x0003e;200&#x000a0;ng and concentration &#x0003e;20&#x000a0;ng/&#x003bc;L was accepted for following steps. Covaris&#x02122; S2&#x000a0;Ultrasonicator System (Covaris, Woburn, MA, USA) was used for DNA segmentation of 150&#x000a0;bp. 200ng DNA for each sample was used for library construction. Library was built in accordance to Agilent SureSelect XT Human All Exon V5 kit (Agilent, CA, USA) guideline. 150&#x000a0;bp paired-end sequencing was performed on Illumina X-ten. Primers for Sanger sequencing were summarized in <xref rid="mmc4" ref-type="supplementary-material">Table&#x000a0;S3</xref>.</p></sec><sec id="sec4.4.3"><title>RNA extraction, library construction and RNA-seq</title><p id="p0235">Total RNA was extracted from freshly frozen FNH and aNL samples using RNAprep Pure Tissue Kit (TIANGENE, Beijing, China) followed by Nanodrop 2000 for quality control with the threshold of total RNA &#x0003e;4&#x000a0;&#x003bc;g. 200&#x000a0;ng RNA for each sample was sent for library construction. We prepared RNA-seq library with NEBNext&#x000ae; Ultra&#x02122; II Directional RNA Library Prep Kit (NEB, MA, USA) for Illumina in accordance with the manufacturer&#x02019;s instructions. 150&#x000a0;bp paired-end sequencing was performed on Illumina X-ten (Illumina, CA, USA).</p></sec><sec id="sec4.4.4"><title>WES data processing, somatic mutation detection</title><p id="p0240">FastQC V1.9 (<ext-link ext-link-type="uri" xlink:href="https://github.com/s-andrews/FastQC" id="intref0155">https://github.com/s-andrews/FastQC</ext-link>) and MultiQC V1.9 (<xref rid="bib28" ref-type="bibr">Ewels et&#x000a0;al., 2016</xref>) were used for quality control of primary WES data, fastp tool V0.20.1 (<xref rid="bib19" ref-type="bibr">Chen et&#x000a0;al., 2018</xref>) was used to filter data and sequence was mapped to hg19 using BWA V0.7.15 (<xref rid="bib48" ref-type="bibr">Li and Durbin, 2010</xref>). We used GATK BaseRecalibrator V4.0.6.0 (<ext-link ext-link-type="uri" xlink:href="https://gatk.broadinstitute.org/hc/en-us/articles/360036898312-BaseRecalibrator" id="intref0160">https://gatk.broadinstitute.org/hc/en-us/articles/360036898312-BaseRecalibrator</ext-link>) to adjust base quality. Filtered data was sent to GATK Mutect2 (<ext-link ext-link-type="uri" xlink:href="https://gatk.broadinstitute.org/hc/en-us/articles/360037593851-Mutect2" id="intref0165">https://gatk.broadinstitute.org/hc/en-us/articles/360037593851-Mutect2</ext-link>) to call somatic mutation followed by Annovar V2017 (<xref rid="bib85" ref-type="bibr">Wang et&#x000a0;al., 2010</xref>) annotation. Mutations with alteration depth&#x000a0;&#x0003c;&#x000a0;5X or total depth of FNH &#x0003c;20X were removed and we used IGV (<ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/software/igv/igvtools" id="intref0170">https://software.broadinstitute.org/software/igv/igvtools</ext-link>) to verify data. Important databases related to Annovar were COSMIC (<ext-link ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cosmic" id="intref0175">http://cancer.sanger.ac.uk/cosmic</ext-link>), dbSNP146 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp" id="intref0180">http://www.ncbi.nlm.nih.gov/snp</ext-link>), 1000genomes (<ext-link ext-link-type="uri" xlink:href="http://www.1000genomes.org/" id="intref0185">http://www.1000genomes.org/</ext-link>) and EXAC (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/" id="intref0190">http://exac.broadinstitute.org/</ext-link>).</p></sec><sec id="sec4.4.5"><title>RNA-seq data processing</title><p id="p0245">Raw data was imported to FastQC V1.9 (<ext-link ext-link-type="uri" xlink:href="https://github.com/s-andrews/FastQC" id="intref0195">https://github.com/s-andrews/FastQC</ext-link>) for quality control and was subsequently sent to fastp V0.20.1 (<xref rid="bib19" ref-type="bibr">Chen et&#x000a0;al., 2018</xref>) for filtering low quality sequence. Reads were mapped to the human genome hg19 with HISAT2 V2.0.5 (<xref rid="bib44" ref-type="bibr">Kim et&#x000a0;al., 2019</xref>) and Cufflinks (<xref rid="bib100" ref-type="bibr">Trapnell et al., 2012</xref>). SAM to BAM transformation was finished by Samtools V1.7 (<xref rid="bib21" ref-type="bibr">Danecek et&#x000a0;al., 2021</xref>). The final count files annotated by gencode.v33.annotation.gtf were produced from FeatureCounts V1.22.2 (<xref rid="bib47" ref-type="bibr">Liao et&#x000a0;al., 2014</xref>) processed BAM files.</p></sec><sec id="sec4.4.6"><title>dN/dS analysis</title><p id="p0250">To estimate whether FNH has positive selection on mutations, we performed dN/dS analysis referred to the previously described method (<xref rid="bib57" ref-type="bibr">Martincorena et&#x000a0;al., 2015</xref>). VCF files including silent and non-silent mutations exported from the WES upstream analysis were imported to dNdScv R package (<xref rid="bib58" ref-type="bibr">Martincorena et&#x000a0;al., 2017</xref>), and genes with wmis_cv, wnon_cv or wind_cv&#x000a0;&#x0003e;&#x000a0;1, and the corresponding q value &#x0003c;0.05 were considered as positive selection. RTCGA and RTCGA.mutations.20160128 packages (<xref rid="bib45" ref-type="bibr">Kosinski and Biecek, 2021</xref>) were used to download TCGA liver hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) mutational information. Same analytical process was also applied to TCGA data.</p></sec><sec id="sec4.4.7"><title>Mutational signature analysis</title><p id="p0255">Due to the relatively low mutationnumber in each sample compared with malignancies, we manually merge SNVs from all 19 samples as one integrated VCF file. Then, the VCF file was imported to maftools R package (<xref rid="bib59" ref-type="bibr">Mayakonda et&#x000a0;al., 2018</xref>) for illustration and further analysis. The mutational signature was acquired using deconstructSigs (<xref rid="bib73" ref-type="bibr">Rosenthal et&#x000a0;al., 2016</xref>), and the cosine similarity was calculated by comparing the signature with COSMIC predefined Mutational Signatures V2. The cosine similarity ranges from 0 to 1, and the closer the number is to 1, the higher the similarity between each pair.</p></sec><sec id="sec4.4.8"><title>Identification of CNVs</title><p id="p0260">Both FNH and aNL BAM files were imported into CNVkit (<xref rid="bib80" ref-type="bibr">Talevich et&#x000a0;al., 2016</xref>), and the aNL file was pooled and set as reference. The final results were generated using default parameter. The copy number was thought to be non-diploid if log<sub>2</sub>(copy number fold change)&#x000a0;&#x0003e;&#x000a0;0.585 or &#x02264; &#x02212;1. And the arm-level changes were defined as &#x02265; 0.1 fold change detected on &#x02265; 50% length of that chromosome arm.</p></sec><sec id="sec4.4.9"><title>Clone number estimation</title><p id="p0265">We estimated clone number with maftools (<xref rid="bib59" ref-type="bibr">Mayakonda et&#x000a0;al., 2018</xref>) and the variant allele frequency (VAF) was used to calculate Mutant-Allele Tumor Heterogeneity (MATH) score. MATH score is a method to measure intra-tumor genetic heterogeneity. When evaluating malignant tumors, high MATH score is correlated to lower survival rate (<xref rid="bib71" ref-type="bibr">Rajput et&#x000a0;al., 2017</xref>). Here, we put this method into benign tumor to estimate whether mutations derived from monoclonal cells. Samples with &#x0003e;5 somatic mutations were calculated.</p></sec><sec id="sec4.4.10"><title>TMB calculation and comparison with TCGA datasets</title><p id="p0270">33 TCGA tumor mutational profiles were acquired with RTCGA and RTCGA.mutations.20160128 packages (<xref rid="bib45" ref-type="bibr">Kosinski and Biecek, 2021</xref>). Setting the filtering depth threshold of our dataset as the reference, we ruled out low quality mutations using the depth-adjusted threshold for TCGA samples. To make our dataset and TCGA datasets comparable, we then adjusted sequenced exome length and sorted each tumor by median mutational number. Mann-Whitney U test was performed between FNH and each tumor, respectively. When considering VAF which means the scale a mutation could affect, we substituted each single point in previous graph with VAF of each mutation. Mann-Whitney U test was performed as described above.</p></sec><sec id="sec4.4.11"><title>DEG detection and pathway analysis</title><p id="p0275">Different expressed genes were identified by DESeq2 (<xref rid="bib49" ref-type="bibr">Love et&#x000a0;al., 2014</xref>) R package V3.12 embedding shrinkage estimation for dispersion and fold change. Read counts were corrected for their patient origin, and genes expressed more than three patients were included for further analysis. We used log2(fold change) &#x02265; 1 or &#x02264; &#x02212;1 and FDR q value &#x0003c;0.05 as the threshold for significant gene selection. For function and pathway enrichment, we used clusterProfiler (<xref rid="bib91" ref-type="bibr">Yu et&#x000a0;al., 2012</xref>) R package V3.14.0 and ToppGene tool (<ext-link ext-link-type="uri" xlink:href="https://toppgene.cchmc.org/enrichment.jsp" id="intref0200">https://toppgene.cchmc.org/enrichment.jsp</ext-link>) implementing canonical database such as KEGG, GO, REACTOME. Results with FDR q value &#x0003c;0.05 was thought significant.</p></sec><sec id="sec4.4.12"><title>PCA of FNH, TCGA and GTEx transcriptome</title><p id="p0280">HCC and CCA read counts were downloaded from GDC portal (<ext-link ext-link-type="uri" xlink:href="https://portal.gdc.cancer.gov/" id="intref0205">https://portal.gdc.cancer.gov/</ext-link>), and normal liver read counts was downloaded from GTEx portal (<ext-link ext-link-type="uri" xlink:href="https://www.gtexportal.org/home" id="intref0210">https://www.gtexportal.org/home</ext-link>). Only protein coding genes were extracted from the original matrixes, and these protein coding matrixes including FNH were merged together. We used DESeq2&#x000a0;R package V3.12 (<xref rid="bib49" ref-type="bibr">Love et&#x000a0;al., 2014</xref>) embedded variance stabilizing transformation that normalizes the count data by dividing the normalization factors. Genes expressed less than 10% of the corresponding sample were excluded from further analysis. PCA was performed using DESeq2&#x000a0;R package described above and the 3D plot was graphed by plot3D R package V1.3 (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=plot3D" id="intref0215">https://CRAN.R-project.org/package=plot3D</ext-link>) using top 3 principle components.</p></sec><sec id="sec4.4.13"><title>Consensus clustering of FNH, TCGA and GTEx samples</title><p id="p0285">Consensus clustering is a method of aggregation of clustering. It refers to that the given clusters of a dataset desire to fit for a better existing clustering. Thus, this algorithm can reconcile data from different samples or results from different runs of an algorithm (<xref rid="bib8" ref-type="bibr">Bonizzoni et&#x000a0;al., 2008</xref>). Therefore, we used consensus clustering embedded ConsensusClusterPlus R package V3.12 (<xref rid="bib86" ref-type="bibr">Wilkerson and Ayes, 2010</xref>) which can also determine the ideal cluster number to comprehensively analyze data from our dataset, TCGA and GTEx. We normalized read count from different dataset via weighted trimmed mean of M-values (TMM) algorithm built in edgeR R package V3.12 (<xref rid="bib72" ref-type="bibr">Robinson et&#x000a0;al., 2009</xref>). We then used median absolute deviation (MAD) to select how many genes were included for the next step. The similarity between each sample and each unsupervised generated cluster was established by 1000 iterations.</p></sec><sec id="sec4.4.14"><title>ICA and correlation with five types of samples</title><p id="p0290">ICA is a decomposition method that extracts a group of independent signal from a multivariate signal. The process can be described as X&#x000a0;= AS, and X represents the raw signal, A is the loading matrix and S is the weight matrix of each independent component (IC). FastICA (<xref rid="bib33" ref-type="bibr">Hyv&#x000e4;rinen and Oja, 2000</xref>), an efficient algorithm implementing ICA, orchestrate Icasso algorithm (<xref rid="bib34" ref-type="bibr">Himberg et&#x000a0;al., 2004</xref>) to synergistically explore the stable IC number and subsequently acquire a robust IC result. We used MATLAB developed BIODICA software windows GUI version (<ext-link ext-link-type="uri" xlink:href="https://github.com/LabBandSB/BIODICA" id="intref0220">https://github.com/LabBandSB/BIODICA</ext-link>) which relies on FastIC and lcasso, running for 100 times respectively for 10 to 70 ICs to inspect the compactness, and finally decided the optimal IC result. Then, the correlation coefficient between each IC and every BIODICA built-in biologically significant gene set. Biologically prominent ICs with correlation coefficient &#x0003e;0.4 were directly entitled as the corresponding name, such as &#x0201c;proliferation&#x0201d; and &#x0201c;fibrosis&#x0201d;. We set the binary vector for each sample within specific type as 1 and outside as 0. To establish the relation between ICs and sample types, we calculated the biserial correlation coefficient between the binary vector and the metasample (sample versus component). Lastly, the simple Pearson correlations were calculated between each IC pairs (<xref rid="bib6" ref-type="bibr">Aynaud et&#x000a0;al., 2020</xref>). In our study, the correlation coefficient &#x0003e;0.5 was considered significant.</p></sec><sec id="sec4.4.15"><title>Annotation of FNH specific IC and samples scoring</title><p id="p0295">The FNH specific metagenes (IC versus genes) were ranked by the contribution factor by decreasing. The ranked list was then imported into GSEA_4.0.3 (<xref rid="bib77" ref-type="bibr">Subramanian et&#x000a0;al., 2005</xref>; <xref rid="bib60" ref-type="bibr">Mootha et&#x000a0;al., 2003</xref>), and GSEA Preranked tool with 1000 permutation was performed. MSigDB V7.2 (<xref rid="bib30" ref-type="bibr">Gouw et&#x000a0;al., 2010</xref>) H, C2, C5 and cell signatures obtained from xCell (<xref rid="bib4" ref-type="bibr">Aran et&#x000a0;al., 2017</xref>) database were set as the standard signature. Terms whose normalized enrichment score (NES)&#x000a0;&#x0003e;&#x000a0;1.5 and FDR q value &#x0003c;0.05 were significant. Of each gene for each IC in metagene matrix, contribution factor &#x0003e;3 were ideal representative for the IC. Therefore, we used the sum of transcripts per million (TPM) of each representative gene as the IC score. Hypothesis testing was carried out using Mann-Whitney U test between FNH and sample x (x&#x000a0;= aNL, TCGA-HCC, TCGA-CCA and GTEx Normal).</p></sec><sec id="sec4.4.16"><title>Single-cell suspension preparation</title><p id="p0300">Three paired freshly resected FNH and aNL samples were immediately transferred into a 4&#x000b0;C DMEM (Gibco, CA, USA) filled 50&#x000a0;mL centrifugal tube with 10% fetal bovine serum (Gibco, CA, USA) and samples were transported to our lab on ice. Clean tissue was trimmed to 5&#x000a0;&#x000d7;&#x000a0;5&#x000a0;&#x000d7;&#x000a0;5&#x000a0;mm in size and was subsequently emerged into 10&#x000a0;mL complex digestive enzyme system including 1&#x000a0;mg/mL collagenase IV (Gibco, CA, USA), and 1&#x000a0;U/mL dispase II (Gibco, CA, USA). The 10&#x000a0;mL system was constantly stirred at 37&#x000b0;C for 40&#x000a0;min. The dissociated solution was filtered through a 40-&#x003bc;m cell-strainer nylon mesh (BD, NJ, USA) followed by 700&#x000a0;g centrifugation for 10&#x000a0;min. Supernatant was removed and the cell sediment was washed twice with MACS solution (PBS containing 1% FBS, 0.5% EDTA, and 0.05% gentamycin). Cells were finally dissolved in sorting buffer (PBS with 1% FBS), stained with DRAQ5 1:200 for 15&#x000a0;min and DAPI 1:200 for 15&#x000a0;min. Living cells were then assessed and sorted by MoFlo Astros EQ (Beckman Coulter, CA, USA) Cell Sorter into 10% FBS DMEM solution. Living cells took up&#x000a0;&#x0003e;&#x000a0;90% of total cells.</p></sec><sec id="sec4.4.17"><title>Library construction and scRNA-sequencing</title><p id="p0305">We used Chromium Single Cell 3&#x02032; Reagent Kits V3 (10&#x000d7; Genomics, CA, USA) to construct libraries according to manufacturer&#x02019;s instructions. We aimed to harvest 6000 cells per cells from each channel. Libraries were constructed using 10&#x000d7; Genomics Single-Cell Instrument and drops were then generated. Samples were sequenced on Illumina NovaSeq.</p></sec><sec id="sec4.4.18"><title>scRNA sequencing data processing</title><p id="p0310">Raw data was processed by Cell Ranger Single-Cell Software TABLE suite (10&#x000d7; Genomics, CA, USA) for doublet removing, barcode processing, alignment and quality control. Reads were mapped to GRCh38 annotated with corresponding annotation files in ENSEMBL database by Cellranger pipline V3.0.1 (<ext-link ext-link-type="uri" xlink:href="https://github.com/10XGenomics/cellranger" id="intref0225">https://github.com/10XGenomics/cellranger</ext-link>). To optimally balance cell number and quality, we kept cells with both 600&#x000a0;&#x0003c;&#x000a0;genes &#x0003c;4000, 1200&#x000a0;&#x0003c;&#x000a0;UMIs &#x0003c;20,000 and percentage of mitochondrial genes &#x0003c;20%. Moreover, we manually checked the marker genes of each cluster and deleted those clusters marked with contradictory canonical genes. A total of 27,474 cells from FNH and 26,747 cells from aNL finally passed the quality control, with 1,686&#x000a0;&#x000b1; 793 (mean&#x000a0;&#x000b1; SD) genes for cells of FNH and 1,387&#x000a0;&#x000b1; 527 (mean&#x000a0;&#x000b1; SD) genes for cells of aNL.</p></sec><sec id="sec4.4.19"><title>Unsupervised clustering and determination of cell type</title><p id="p0315">We used log-transformed method to normalize counts and the top 2000 highly variable genes were subsequently scaled for principle component analysis. Seurat V3.2.3 (<xref rid="bib76" ref-type="bibr">Stuart et&#x000a0;al., 2019</xref>) embedding Harmony algorithm (<xref rid="bib39" ref-type="bibr">Korsunsky et&#x000a0;al., 2019</xref>), a strong method to minimize technical or biological confounders to integrate different datasets and preserve biological characteristics was used to combine cells derived from three patients. Top 20 principle components were used for clustering and Uniform Manifold Approximation and Projection (UMAP) was applied for visualization. Marker genes were detected using FindAllMarker function. Genes expressed in &#x0003e;25% cells in each cluster and log2(fold change) &#x02265; 1 were recognized as marker genes. Next, we employed singleR V1.0.6&#x000a0;R package (<xref rid="bib5" ref-type="bibr">Aran et&#x000a0;al., 2019</xref>) to preliminarily annotate clusters followed by manual verification using canonical marker genes published in papers or documented in databases.</p></sec><sec id="sec4.4.20"><title>Deconvolution of RNA-seq data</title><p id="p0320">Our bulk RNA-seq data was deconvoluted using Cibersortx (<xref rid="bib61" ref-type="bibr">Newman et&#x000a0;al., 2019</xref>), LM22 signature matrix was used as background reference and 500 permutations were applied. Absolute mode was finally set to acquire results.</p></sec><sec id="sec4.4.21"><title>Pseudo-bulk sample generation</title><p id="p0325">The pseudo-bulk samples were generated by adding all single-cell read counts individually. Genes expressed by less than 10 cells were excluded from analysis and DEG and pathway enrichment analysis were performed the same way described in &#x0201c;Differentially Expressed Genes Detection and Pathway Analysis&#x0201d;. DEGs with adjusted p value &#x0003c;0.05 and |log<sub>2</sub>(fold change)| &#x02265; 1 were considered significant.</p></sec><sec id="sec4.4.22"><title>Gene set enrichment of single-cell data</title><p id="p0330">Gene set variation analysis (GSVA), depending on a non-parametric unsupervised method, transform an expression matrix into a relative enrichment score matrix. The count files were scaled to conform to Gaussian distribution and imported into GSVA function. For visualization, we used z-score to plot heatmap.</p></sec><sec id="sec4.4.23"><title>Pseudo-trajectory inference</title><p id="p0335">We used Monocle V2.12.0&#x000a0;R package (<xref rid="bib78" ref-type="bibr">Trapnell et&#x000a0;al., 2014</xref>) to construct the pseudo-trajectory of endothelial cells. Differentially expressed genes (expressed &#x0003e;10% cells) were chosen using differentialGeneTest function and the genes with FDR q value &#x0003c;0.01 were selected for DDRTree which is responsible for trajectory construction.</p></sec><sec id="sec4.4.24"><title>Metabolic gene signature scoring</title><p id="p0340">We obtained metabolic gene signatures from the published article (<xref rid="bib78" ref-type="bibr">Trapnell et&#x000a0;al., 2014</xref>). Both Seurat object and signature genes were imported to AddModuleScore function of Seurat, which calculates the difference of the average expression of target genes and control genes randomly sampled from each bin. We set 100 control genes and 24 bins for analysis. Each cell would get a score of the signature.</p></sec><sec id="sec4.4.25"><title>Intercellular ligand-receptor analysis</title><p id="p0345">We used CellPhoneDB V2.0 to infer the ligand-receptor crosstalk between single cells (<xref rid="bib27" ref-type="bibr">Efremova et&#x000a0;al., 2020</xref>). Significant secreting ligand and receptor was selected and visualized by ggplot2 (<xref rid="bib88" ref-type="bibr">Wickham, 2011</xref>) and ggsci (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=ggsci" id="interref0010">https://CRAN.R-project.org/package=ggsci</ext-link>).</p></sec><sec id="sec4.4.26"><title>Immunofluorescence and immunohistochemistry</title><p id="p0350">The paraffin section was baked for 1&#x000a0;h and dewaxed by 10&#x000a0;min xylene for three times followed by 100%, 95%, 85% and 75% gradient dehydration. Then, the section was washed for twice and placed in boiling antigen retrieval buffer (citrate PH&#x000a0;= 6 or EDTA PH&#x000a0;= 9) for 10&#x000a0;min. Next, the section was incubated with 3% H<sub>2</sub>O<sub>2</sub> for 10&#x000a0;min for blocking endogenous peroxidase. Non-specific binding was blocked by goat serum (Vector, CA, USA) for 30&#x000a0;min. The section was incubated with primary antibody over night at 4&#x000b0;C or for 1hat room temperature. After washing for three times, the section was then incubated with corresponding second antibody for 25&#x000a0;min. Following three-time washing, Opal&#x000ae; (PerkinElmer, MA, USA) fluorescence dye kit was used to stain the target. The whole process from antigen retrieval to fluorescence staining was repeated till the last marker was finished. Finally, nuclei were stained using DAPI (Sigma-Aldrich, USA) and slides were mounted with fluorescence mounting media (DAKO, CA, USA). Slides were scanned and analyzed using PerkinElmer Vectra3&#x000ae; platform.</p><p id="p0355">Immunohistochemistry followed the same steps as immunofluorescence, however, after second body incubation, the section was processed stepwise by hematoxylin, acidic differentiation solution and bluing buffer. Then, the section was dehydrated by 100% ethanol and xylene followed by resin mounting.</p></sec><sec id="sec4.4.27"><title>RNA extraction and qRT-PCR</title><p id="p0360">Frozen tissue was minced thoroughly in liquid nitrogen precooled mortar into powder. After liquid nitrogen completely evaporated, 1&#x000a0;mL Trizol (Invitrogen, CA, USA) was added followed by 200&#x000a0;&#x003bc;L chloroform. Centrifugation was performed and the supernatant was moved to 500 &#x003bc;L isopropanol for RNA precipitation. Centrifugation was performed again and 75% ethanol (prepared with DEPC water) was added for washing.</p><p id="p0365">RNA with OD260/OD280&#x000a0;&#x0003e;&#x000a0;1.8 was considered qualified. Reverse transcription and qRT-PCR were performed according to the manufacturer&#x02019;s instruction (Yeasen, Shanghai, China) using QuantStudio 3 (ABI, MA, USA).</p><p id="p0370">Primers for MARCO:</p><p id="p0375">F: CGTCAGGATTGTCGGCAGTA.</p><p id="p0380">R: CCTTTGGAGTAACCCAGCAT.</p></sec><sec id="sec4.4.28"><title>RNA <italic>in situ</italic> hybrization</title><p id="p0385">RNAscope&#x000ae; 2.5 HD Assay - Brown and RNAscope&#x000ae; SOST Probes were purchased from Advanced Cell Diagnostics (ACD, CA, USA). Freshly resected FNH tissue was immediately transferred to cold PBS to remove as much blood as possible. Then, samples were immerged in 10% neutral buffered formalin for 24&#x000a0;h for paraffin embedding. After deparaffinized, RNAscope&#x000ae; Hydrogen Peroxide and RNAscope&#x000ae; Target Retrieval Reagents were used to quench endogenous peroxidase and retrieve antigens respectively, followed by protein digestion using RNAscope&#x000ae; Protease Plus. Finally, targeted RNA was hybridized by SOST probe and RNAscope&#x000ae; 2.5 HD Detection Reagents &#x02013; BROWN was used to amplified the signal.</p></sec></sec><sec id="sec4.5"><title>Quantification and statistical analysis</title><sec id="sec4.5.1"><title>Statistical analysis</title><p id="p0390">Standard statistical methods were utilized, including Student&#x02019;s t test, Paired Student&#x02019;s t test and Mann-Whitney U test. For clinical data comparison, single-omic and multi-omic analyses, Student&#x02019;s t test was used to compare the age and tumor size between two gender groups. Mann-Whitney U test was applied to the comparison of TMB or VAF-TMB between FNH and each TCGA tumor samples, IC scores between FNH and each type of samples. For experiment data, Student&#x02019;s t test was used to compare the MARCO expression level between FNH and HCC. Paired Student&#x02019;s t test was utilized to measure the content difference of macrophages between FNH and paired aNL. All statistical tests were two-sided, and statistical significance was considered when P value&#x000a0;&#x0003c;&#x000a0;0.05. for continuous variables versus continuous variables, Spearman&#x02019;s rank or Pearson correlation was used. For category versus continuous variables, the point-biserial correlation was used. Statistical analysis was performed using GraphPad Prism 8. Correlation analyses were performed in R v3.6.3. Data were represented using the mean&#x000a0;&#x000b1; standard deviation (SD), unless indicated otherwise.</p></sec></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib102"><element-citation publication-type="journal" id="sref102"><person-group person-group-type="author"><name><surname>Aizarani</surname><given-names>N.</given-names></name><name><surname>Saviano</surname><given-names>A.</given-names></name><name><surname>Sagar</surname></name><name><surname>Mailly</surname><given-names>L.</given-names></name><name><surname>Durand</surname><given-names>S.</given-names></name><name><surname>Herman</surname><given-names>J.S.</given-names></name><name><surname>Pessaux</surname><given-names>P.</given-names></name><name><surname>Baumert</surname><given-names>T.F.</given-names></name><name><surname>Gr&#x000fc;n</surname><given-names>D.</given-names></name></person-group><article-title>A human liver cell atlas reveals heterogeneity and epithelial progenitors</article-title><source>Nature</source><volume>572</volume><year>2019</year><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1373-2</pub-id><pub-id pub-id-type="pmid">31292543</pub-id></element-citation></ref><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Aldinger</surname><given-names>K.</given-names></name></person-group><article-title>Focal nodular hyperplasia of the liver associated with high-dosage estrogens</article-title><source>Arch. Intern. Med.</source><volume>137</volume><year>1977</year><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1001/archinte.1977.03630150057016</pub-id><pub-id pub-id-type="pmid">190958</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Alexandrov</surname><given-names>L.B.</given-names></name><name><surname>Nik-Zainal</surname><given-names>S.</given-names></name><name><surname>Wedge</surname><given-names>D.C.</given-names></name><name><surname>Aparicio</surname><given-names>S.A.J.R.</given-names></name><name><surname>Behjati</surname><given-names>S.</given-names></name><name><surname>Biankin</surname><given-names>A.V.</given-names></name><name><surname>Bignell</surname><given-names>G.R.</given-names></name><name><surname>Bolli</surname><given-names>N.</given-names></name><name><surname>Borg</surname><given-names>A.</given-names></name><name><surname>B&#x000f8;rresen-Dale</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>Signatures of mutational processes in human cancer</article-title><source>Nature</source><volume>500</volume><year>2013</year><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nature12477</pub-id><pub-id pub-id-type="pmid">23945592</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Amatschek</surname><given-names>S.</given-names></name><name><surname>Kriehuber</surname><given-names>E.</given-names></name><name><surname>Bauer</surname><given-names>W.</given-names></name><name><surname>Reininger</surname><given-names>B.</given-names></name><name><surname>Meraner</surname><given-names>P.</given-names></name><name><surname>Wolpl</surname><given-names>A.</given-names></name><name><surname>Schweifer</surname><given-names>N.</given-names></name><name><surname>Haslinger</surname><given-names>C.</given-names></name><name><surname>Stingl</surname><given-names>G.</given-names></name><name><surname>Maurer</surname><given-names>D.</given-names></name></person-group><article-title>Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment</article-title><source>Blood</source><volume>109</volume><year>2007</year><fpage>4777</fpage><lpage>4785</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-10-053280</pub-id><pub-id pub-id-type="pmid">17289814</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Butte</surname><given-names>A.J.</given-names></name></person-group><article-title>Xcell: digitally portraying the tissue cellular heterogeneity landscape</article-title><source>Genome Biol.</source><volume>18</volume><year>2017</year><fpage>220</fpage><pub-id pub-id-type="doi">10.1186/s13059-017-1349-1</pub-id><pub-id pub-id-type="pmid">29141660</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>D.</given-names></name><name><surname>Looney</surname><given-names>A.P.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>E.</given-names></name><name><surname>Fong</surname><given-names>V.</given-names></name><name><surname>Hsu</surname><given-names>A.</given-names></name><name><surname>Chak</surname><given-names>S.</given-names></name><name><surname>Naikawadi</surname><given-names>R.P.</given-names></name><name><surname>Wolters</surname><given-names>P.J.</given-names></name><name><surname>Abate</surname><given-names>A.R.</given-names></name><etal/></person-group><article-title>Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage</article-title><source>Nat. Immunol.</source><volume>20</volume><year>2019</year><fpage>163</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0276-y</pub-id><pub-id pub-id-type="pmid">30643263</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Aynaud</surname><given-names>M.M.</given-names></name><name><surname>Mirabeau</surname><given-names>O.</given-names></name><name><surname>Gruel</surname><given-names>N.</given-names></name><name><surname>Grosset&#x000ea;te</surname><given-names>S.</given-names></name><name><surname>Boeva</surname><given-names>V.</given-names></name><name><surname>Durand</surname><given-names>S.</given-names></name><name><surname>Surdez</surname><given-names>D.</given-names></name><name><surname>Saulnier</surname><given-names>O.</given-names></name><name><surname>Za&#x000ef;di</surname><given-names>S.</given-names></name><name><surname>Gribkova</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Transcriptional programs define intratumoral heterogeneity of Ewing sarcoma at single-cell resolution</article-title><source>Cell Rep.</source><volume>30</volume><year>2020</year><fpage>1767</fpage><lpage>1779.e6</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.01.049</pub-id><pub-id pub-id-type="pmid">32049009</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Bioulac Sage</surname><given-names>P.</given-names></name><name><surname>Laumonier</surname><given-names>H.</given-names></name><name><surname>Rullier</surname><given-names>A.</given-names></name><name><surname>Cubel</surname><given-names>G.</given-names></name><name><surname>Laurent</surname><given-names>C.</given-names></name><name><surname>Zucman Rossi</surname><given-names>J.</given-names></name><name><surname>Balabaud</surname><given-names>C.</given-names></name></person-group><article-title>Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology</article-title><source>Liver Int.</source><volume>29</volume><year>2009</year><fpage>459</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1111/j.1478-3231.2008.01849.x</pub-id><pub-id pub-id-type="pmid">18803590</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Bonizzoni</surname><given-names>P.</given-names></name><name><surname>Della Vedova</surname><given-names>G.</given-names></name><name><surname>Dondi</surname><given-names>R.</given-names></name><name><surname>Jiang</surname><given-names>T.</given-names></name></person-group><article-title>On the approximation of correlation clustering and consensus clustering</article-title><source>J.&#x000a0;Comput. Syst. Sci.</source><volume>74</volume><year>2008</year><fpage>671</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.jcss.2007.06.024</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Brunner</surname><given-names>S.F.</given-names></name><name><surname>Roberts</surname><given-names>N.D.</given-names></name><name><surname>Wylie</surname><given-names>L.A.</given-names></name><name><surname>Moore</surname><given-names>L.</given-names></name><name><surname>Aitken</surname><given-names>S.J.</given-names></name><name><surname>Davies</surname><given-names>S.E.</given-names></name><name><surname>Sanders</surname><given-names>M.A.</given-names></name><name><surname>Ellis</surname><given-names>P.</given-names></name><name><surname>Alder</surname><given-names>C.</given-names></name><name><surname>Hooks</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Somatic mutations and clonal dynamics in healthy and cirrhotic human liver</article-title><source>Nature</source><volume>574</volume><year>2019</year><fpage>538</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1670-9</pub-id><pub-id pub-id-type="pmid">31645727</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Captier</surname><given-names>N.</given-names></name><name><surname>Merlevede</surname><given-names>J.</given-names></name><name><surname>Molkenov</surname><given-names>A.</given-names></name><name><surname>Seisenova</surname><given-names>A.</given-names></name><name><surname>Zhubanchaliyev</surname><given-names>A.</given-names></name><name><surname>Nazarov</surname><given-names>P.V.</given-names></name><name><surname>Barillot</surname><given-names>E.</given-names></name><name><surname>Kairov</surname><given-names>U.</given-names></name><name><surname>Zinovyev</surname><given-names>A.</given-names></name></person-group><article-title>BIODICA: a computational environment for independent component analysis</article-title><source>Bioinformatics</source><volume>38</volume><year>2022</year><fpage>2963</fpage><lpage>2964</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btac204</pub-id><pub-id pub-id-type="pmid">35561190</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.X.</given-names></name><name><surname>Weng</surname><given-names>Z.H.</given-names></name><name><surname>Zhang</surname><given-names>S.L.</given-names></name></person-group><article-title>Notch3 regulates the activation of hepatic stellate cells</article-title><source>World J. Gastroenterol.</source><volume>18</volume><year>2012</year><fpage>1397</fpage><lpage>1403</lpage><pub-id pub-id-type="doi">10.3748/wjg.v18.i12.1397</pub-id><pub-id pub-id-type="pmid">22493555</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Campisi</surname><given-names>J.</given-names></name><name><surname>D'Adda</surname><given-names>D.F.F.</given-names></name></person-group><article-title>Cellular senescence: when bad things happen to good cells</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>8</volume><year>2007</year><fpage>729</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1038/nrm2233</pub-id><pub-id pub-id-type="pmid">17667954</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y.R.</given-names></name><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Teng</surname><given-names>X.Y.</given-names></name><name><surname>Zhang</surname><given-names>H.T.</given-names></name><name><surname>Wang</surname><given-names>C.F.</given-names></name><name><surname>Wei</surname><given-names>G.L.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Ding</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Z.H.</given-names></name><name><surname>Pan</surname><given-names>Q.J.</given-names></name><name><surname>Su</surname><given-names>Q.</given-names></name></person-group><article-title>Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma</article-title><source>World J. Gastroenterol.</source><volume>15</volume><year>2009</year><fpage>4695</fpage><lpage>4708</lpage><pub-id pub-id-type="doi">10.3748/wjg.15.4695</pub-id><pub-id pub-id-type="pmid">19787833</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Cairns</surname><given-names>J.</given-names></name></person-group><article-title>Mutation selection and the natural history of cancer</article-title><source>Nature</source><volume>255</volume><year>1975</year><fpage>197</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/255197a0</pub-id><pub-id pub-id-type="pmid">1143315</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.C.</given-names></name><name><surname>Chou</surname><given-names>T.B.</given-names></name><name><surname>Ng</surname><given-names>K.F.</given-names></name><name><surname>Hsieh</surname><given-names>L.L.</given-names></name><name><surname>Chou</surname><given-names>Y.H.</given-names></name></person-group><article-title>Hepatocellular carcinoma associated with focal nodular hyperplasia</article-title><source>Virchows Arch.</source><volume>438</volume><year>2001</year><fpage>408</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1007/s004280000348</pub-id><pub-id pub-id-type="pmid">11355178</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Colom</surname><given-names>B.</given-names></name><name><surname>Alcolea</surname><given-names>M.P.</given-names></name><name><surname>Piedrafita</surname><given-names>G.</given-names></name><name><surname>Hall</surname><given-names>M.W.J.</given-names></name><name><surname>Wabik</surname><given-names>A.</given-names></name><name><surname>Dentro</surname><given-names>S.C.</given-names></name><name><surname>Fowler</surname><given-names>J.C.</given-names></name><name><surname>Herms</surname><given-names>A.</given-names></name><name><surname>King</surname><given-names>C.</given-names></name><name><surname>Ong</surname><given-names>S.H.</given-names></name><etal/></person-group><article-title>Spatial competition shapes the dynamic mutational landscape of normal esophageal epithelium</article-title><source>Nat. Genet.</source><volume>52</volume><year>2020</year><fpage>604</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-0624-3</pub-id><pub-id pub-id-type="pmid">32424351</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>Luo</surname><given-names>L.L.</given-names></name><name><surname>Chen</surname><given-names>W.W.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>R.R.</given-names></name><name><surname>Zhao</surname><given-names>Y.L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yue</surname><given-names>J.</given-names></name></person-group><article-title>Polymorphism in the EREG gene confers susceptibility to tuberculosis</article-title><source>BMC Med. Genet.</source><volume>20</volume><year>2019</year><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s12881-018-0729-z</pub-id><pub-id pub-id-type="pmid">30634928</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Qu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Wan</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name></person-group><article-title>CXCL6-EGFR-induced Kupffer cells secrete TGF-&#x003b2;1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis</article-title><source>J.&#x000a0;Cell Mol. Med.</source><volume>22</volume><year>2018</year><fpage>5050</fpage><lpage>5061</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13787</pub-id><pub-id pub-id-type="pmid">30106235</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name></person-group><article-title>Fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><volume>34</volume><year>2018</year><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id><pub-id pub-id-type="pmid">30423086</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Czochra</surname><given-names>P.</given-names></name><name><surname>Klopcic</surname><given-names>B.</given-names></name><name><surname>Meyer</surname><given-names>E.</given-names></name><name><surname>Herkel</surname><given-names>J.</given-names></name><name><surname>Garcia-Lazaro</surname><given-names>J.F.</given-names></name><name><surname>Thieringer</surname><given-names>F.</given-names></name><name><surname>Schirmacher</surname><given-names>P.</given-names></name><name><surname>Biesterfeld</surname><given-names>S.</given-names></name><name><surname>Galle</surname><given-names>P.R.</given-names></name><name><surname>Lohse</surname><given-names>A.W.</given-names></name><name><surname>Kanzler</surname><given-names>S.</given-names></name></person-group><article-title>Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice</article-title><source>J.&#x000a0;Hepatol.</source><volume>45</volume><year>2006</year><fpage>419</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2006.04.010</pub-id><pub-id pub-id-type="pmid">16842882</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P.</given-names></name><name><surname>Bonfield</surname><given-names>J.K.</given-names></name><name><surname>Liddle</surname><given-names>J.</given-names></name><name><surname>Marshall</surname><given-names>J.</given-names></name><name><surname>Ohan</surname><given-names>V.</given-names></name><name><surname>Pollard</surname><given-names>M.O.</given-names></name><name><surname>Whitwham</surname><given-names>A.</given-names></name><name><surname>Keane</surname><given-names>T.</given-names></name><name><surname>McCarthy</surname><given-names>S.A.</given-names></name><name><surname>Davies</surname><given-names>R.M.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>Twelve years of SAMtools and BCFtools</article-title><source>GigaScience</source><volume>10</volume><year>2021</year><fpage>giab008</fpage><pub-id pub-id-type="doi">10.1093/gigascience/giab008</pub-id><pub-id pub-id-type="pmid">33590861</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Deraz</surname><given-names>E.M.</given-names></name><name><surname>Kudo</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Obayashi</surname><given-names>M.</given-names></name><name><surname>Tsunematsu</surname><given-names>T.</given-names></name><name><surname>Tani</surname><given-names>H.</given-names></name><name><surname>Siriwardena</surname><given-names>S.B.S.M.</given-names></name><name><surname>Keikhaee</surname><given-names>M.R.</given-names></name><name><surname>Kiekhaee</surname><given-names>M.R.</given-names></name><name><surname>Qi</surname><given-names>G.</given-names></name><etal/></person-group><article-title>MMP-10/stromelysin-2 promotes invasion of head and neck cancer</article-title><source>PLoS One</source><volume>6</volume><year>2011</year><fpage>e25438</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0025438</pub-id><pub-id pub-id-type="pmid">21998657</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>L.Q.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>L.J.</given-names></name><name><surname>Yang</surname><given-names>L.X.</given-names></name><name><surname>Wang</surname><given-names>X.Y.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.C.</given-names></name><name><surname>Duan</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>L.Z.</given-names></name><etal/></person-group><article-title>Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma</article-title><source>J.&#x000a0;Hepatol.</source><volume>69</volume><year>2018</year><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.02.029</pub-id><pub-id pub-id-type="pmid">29551704</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>de Haan</surname><given-names>W.</given-names></name><name><surname>&#x000d8;ie</surname><given-names>C.</given-names></name><name><surname>Benkheil</surname><given-names>M.</given-names></name><name><surname>Dheedene</surname><given-names>W.</given-names></name><name><surname>Vinckier</surname><given-names>S.</given-names></name><name><surname>Coppiello</surname><given-names>G.</given-names></name><name><surname>Aranguren</surname><given-names>X.L.</given-names></name><name><surname>Beerens</surname><given-names>M.</given-names></name><name><surname>Jaekers</surname><given-names>J.</given-names></name><name><surname>Topal</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Unraveling the transcriptional determinants of liver sinusoidal endothelial cell specialization</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><volume>318</volume><year>2020</year><fpage>G803</fpage><lpage>G815</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00215.2019</pub-id><pub-id pub-id-type="pmid">32116021</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Diez</surname><given-names>H.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Winkler</surname><given-names>A.</given-names></name><name><surname>Hu</surname><given-names>C.J.</given-names></name><name><surname>Hatzopoulos</surname><given-names>A.K.</given-names></name><name><surname>Breier</surname><given-names>G.</given-names></name><name><surname>Gessler</surname><given-names>M.</given-names></name></person-group><article-title>Hypoxia-mediated activation of DLL4-NOTCH-HEY2 signaling in endothelial progenitor cells and adoption of arterial cell fate</article-title><source>Exp. Cell Res.</source><volume>313</volume><year>2007</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.09.009</pub-id><pub-id pub-id-type="pmid">17045587</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><collab>EASL</collab></person-group><article-title>EASL clinical practice guidelines on the management of benign liver tumours</article-title><source>J.&#x000a0;Hepatol.</source><volume>65</volume><year>2016</year><fpage>386</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">27085809</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Efremova</surname><given-names>M.</given-names></name><name><surname>Vento-Tormo</surname><given-names>M.</given-names></name><name><surname>Teichmann</surname><given-names>S.A.</given-names></name><name><surname>Vento-Tormo</surname><given-names>R.</given-names></name></person-group><article-title>CellphoneDB: inferring cell&#x02013;cell communication from combined expression of multi-subunit ligand&#x02013;receptor complexes</article-title><source>Nat. Protoc.</source><volume>15</volume><year>2020</year><fpage>1484</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id><pub-id pub-id-type="pmid">32103204</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>P.</given-names></name><name><surname>Magnusson</surname><given-names>M.</given-names></name><name><surname>Lundin</surname><given-names>S.</given-names></name><name><surname>K&#x000e4;ller</surname><given-names>M.</given-names></name></person-group><article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title><source>Bioinformatics</source><volume>32</volume><year>2016</year><fpage>3047</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2017.03.001</pub-id><pub-id pub-id-type="pmid">27312411</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>A.</given-names></name><name><surname>Totoki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>T.</given-names></name><name><surname>Boroevich</surname><given-names>K.A.</given-names></name><name><surname>Hosoda</surname><given-names>F.</given-names></name><name><surname>Nguyen</surname><given-names>H.H.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Hosono</surname><given-names>N.</given-names></name><name><surname>Kubo</surname><given-names>M.</given-names></name><name><surname>Miya</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators</article-title><source>Nat. Genet.</source><volume>44</volume><year>2012</year><fpage>760</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1038/ng.2291</pub-id><pub-id pub-id-type="pmid">22634756</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Gouw</surname><given-names>A.S.H.</given-names></name><name><surname>Zeng</surname><given-names>W.</given-names></name><name><surname>Buiskool</surname><given-names>M.</given-names></name><name><surname>Platteel</surname><given-names>I.</given-names></name><name><surname>van den Heuvel</surname><given-names>M.C.</given-names></name><name><surname>Poppema</surname><given-names>S.</given-names></name><name><surname>de Jong</surname><given-names>K.P.</given-names></name><name><surname>Molema</surname><given-names>G.</given-names></name></person-group><article-title>Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: a role for angiopoietin-1</article-title><source>Hepatology</source><volume>52</volume><year>2010</year><fpage>540</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1002/hep.23700</pub-id><pub-id pub-id-type="pmid">20683953</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Hirakawa</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>Y.K.</given-names></name><name><surname>Harvey</surname><given-names>N.</given-names></name><name><surname>Schacht</surname><given-names>V.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Libermann</surname><given-names>T.</given-names></name><name><surname>Detmar</surname><given-names>M.</given-names></name></person-group><article-title>Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells</article-title><source>Am. J. Pathol.</source><volume>162</volume><year>2003</year><fpage>575</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)63851-5</pub-id><pub-id pub-id-type="pmid">12547715</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>S.H.</given-names></name><name><surname>Bosch</surname><given-names>F.X.</given-names></name><name><surname>Troxell</surname><given-names>T.C.</given-names></name><name><surname>Bolger</surname><given-names>P.M.</given-names></name></person-group><article-title>Public health: reducing liver cancer-global control of aflatoxin</article-title><source>Science</source><volume>286</volume><year>1999</year><fpage>2453</fpage><lpage>2454</lpage><pub-id pub-id-type="doi">10.1126/science.286.5449.2453</pub-id><pub-id pub-id-type="pmid">10636808</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Hyv&#x000e4;rinen</surname><given-names>A.</given-names></name><name><surname>Oja</surname><given-names>E.</given-names></name></person-group><article-title>Independent component analysis: algorithms and applications</article-title><source>Neural Netw.</source><volume>13</volume><year>2000</year><fpage>411</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/S0893-6080(00)00026-5</pub-id><pub-id pub-id-type="pmid">10946390</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Himberg</surname><given-names>J.</given-names></name><name><surname>Hyv&#x000e4;rinen</surname><given-names>A.</given-names></name><name><surname>Esposito</surname><given-names>F.</given-names></name></person-group><article-title>Validating the independent components of neuroimaging time series via clustering and visualization</article-title><source>Neuroimage</source><volume>22</volume><year>2004</year><fpage>1214</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.03.027</pub-id><pub-id pub-id-type="pmid">15219593</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Idogawa</surname><given-names>M.</given-names></name><name><surname>Hida</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Ohira</surname><given-names>N.</given-names></name><name><surname>Tange</surname><given-names>S.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Uhara</surname><given-names>H.</given-names></name><name><surname>Masumori</surname><given-names>N.</given-names></name><name><surname>Tokino</surname><given-names>T.</given-names></name><name><surname>Natori</surname><given-names>H.</given-names></name></person-group><article-title>Renal angiomyolipoma harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity</article-title><source>Cancer Biol. Ther.</source><volume>21</volume><year>2020</year><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1080/15384047.2019.1702406</pub-id><pub-id pub-id-type="pmid">31847710</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Jongkind</surname><given-names>J.F.</given-names></name><name><surname>Verkerk</surname><given-names>A.</given-names></name><name><surname>Baggen</surname><given-names>R.G.</given-names></name></person-group><article-title>Glutathione metabolism of human vascular endothelial cells under peroxidative stress</article-title><source>Free Radic. Biol. Med.</source><volume>7</volume><year>1989</year><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(99)00216-8</pub-id><pub-id pub-id-type="pmid">2612962</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Jee</surname><given-names>B.A.</given-names></name><name><surname>Choi</surname><given-names>J.H.</given-names></name><name><surname>Rhee</surname><given-names>H.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name><name><surname>Kwon</surname><given-names>S.M.</given-names></name><name><surname>Nahm</surname><given-names>J.H.</given-names></name><name><surname>Yoo</surname><given-names>J.E.</given-names></name><name><surname>Jeon</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>G.H.</given-names></name><name><surname>Woo</surname><given-names>H.G.</given-names></name><name><surname>Park</surname><given-names>Y.N.</given-names></name></person-group><article-title>Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis</article-title><source>Cancer Res.</source><volume>79</volume><year>2019</year><fpage>5500</fpage><lpage>5512</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-0991</pub-id><pub-id pub-id-type="pmid">31506333</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Kakiuchi</surname><given-names>N.</given-names></name><name><surname>Ogawa</surname><given-names>S.</given-names></name></person-group><article-title>Clonal expansion in non-cancer tissues</article-title><source>Nat. Rev. Cancer</source><volume>21</volume><year>2021</year><fpage>239</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1038/s41568-021-00335-3</pub-id><pub-id pub-id-type="pmid">33627798</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I.</given-names></name><name><surname>Millard</surname><given-names>N.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Slowikowski</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Wei</surname><given-names>K.</given-names></name><name><surname>Baglaenko</surname><given-names>Y.</given-names></name><name><surname>Brenner</surname><given-names>M.</given-names></name><name><surname>Loh</surname><given-names>P.R.</given-names></name><name><surname>Raychaudhuri</surname><given-names>S.</given-names></name></person-group><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nat. Methods</source><volume>16</volume><year>2019</year><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Koea</surname><given-names>J.B.</given-names></name><name><surname>Yeong</surname><given-names>M.L.</given-names></name></person-group><article-title>Focal nodular hyperplasia and hepatocellular carcinoma: uncommon companions?</article-title><source>Pathology</source><volume>46</volume><year>2014</year><fpage>348</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1097/PAT.0000000000000102</pub-id><pub-id pub-id-type="pmid">24798151</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Kudo</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>R.Q.</given-names></name><name><surname>Chung</surname><given-names>H.</given-names></name><name><surname>Yonekura</surname><given-names>T.</given-names></name><name><surname>Yagi</surname><given-names>M.</given-names></name><name><surname>Nakashima</surname><given-names>O.</given-names></name><name><surname>Kojiro</surname><given-names>M.</given-names></name></person-group><article-title>Long-term follow-up of atypical progressive focal nodular hyperplasia increasing in size and number implicates its pathogenesis</article-title><source>Am. J. Gastroenterol.</source><volume>103</volume><year>2008</year><fpage>2153</fpage><lpage>2155</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2008.01982_14.x</pub-id><pub-id pub-id-type="pmid">18796122</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Kisseleva</surname><given-names>T.</given-names></name><name><surname>Brenner</surname><given-names>D.</given-names></name></person-group><article-title>Molecular and cellular mechanisms of liver fibrosis and its regression</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><volume>18</volume><year>2021</year><fpage>151</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1038/s41575-020-00372-7</pub-id><pub-id pub-id-type="pmid">33128017</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Khursheed</surname><given-names>M.</given-names></name><name><surname>Kolla</surname><given-names>J.N.</given-names></name><name><surname>Kotapalli</surname><given-names>V.</given-names></name><name><surname>Gupta</surname><given-names>N.</given-names></name><name><surname>Gowrishankar</surname><given-names>S.</given-names></name><name><surname>Uppin</surname><given-names>S.G.</given-names></name><name><surname>Sastry</surname><given-names>R.A.</given-names></name><name><surname>Koganti</surname><given-names>S.</given-names></name><name><surname>Sundaram</surname><given-names>C.</given-names></name><name><surname>Pollack</surname><given-names>J.R.</given-names></name><name><surname>Bashyam</surname><given-names>M.D.</given-names></name></person-group><article-title>ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines</article-title><source>Br. J. Cancer</source><volume>108</volume><year>2013</year><fpage>2056</fpage><lpage>2062</lpage><pub-id pub-id-type="doi">10.1038/bjc.2013.200</pub-id><pub-id pub-id-type="pmid">23660946</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Paggi</surname><given-names>J.M.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name><name><surname>Bennett</surname><given-names>C.</given-names></name><name><surname>Salzberg</surname><given-names>S.L.</given-names></name></person-group><article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title><source>Nat. Biotechnol.</source><volume>37</volume><year>2019</year><fpage>907</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id><pub-id pub-id-type="pmid">31375807</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="other" id="sref45"><person-group person-group-type="author"><name><surname>Kosinski</surname><given-names>M.</given-names></name><name><surname>Biecek</surname><given-names>P.</given-names></name></person-group><article-title>RTCGA: the cancer genome atlas data integration</article-title><comment>R Package Version 1.24.0</comment><ext-link ext-link-type="uri" xlink:href="https://rtcga.github.io/RTCGA" id="intref0235">https://rtcga.github.io/RTCGA</ext-link><year>2021</year></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Liberzon</surname><given-names>A.</given-names></name><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Pinchback</surname><given-names>R.</given-names></name><name><surname>Thorvaldsd&#x000f3;ttir</surname><given-names>H.</given-names></name><name><surname>Tamayo</surname><given-names>P.</given-names></name><name><surname>Mesirov</surname><given-names>J.P.</given-names></name></person-group><article-title>Molecular signatures database (MSigDB) 3.0</article-title><source>Bioinformatics</source><volume>27</volume><year>2011</year><fpage>1739</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr260</pub-id><pub-id pub-id-type="pmid">21546393</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y.</given-names></name><name><surname>Smyth</surname><given-names>G.K.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name></person-group><article-title>FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><year>2014</year><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Durbin</surname><given-names>R.</given-names></name></person-group><article-title>Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title><source>Bioinformatics</source><volume>26</volume><year>2010</year><fpage>589</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id><pub-id pub-id-type="pmid">20080505</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Love</surname><given-names>M.I.</given-names></name><name><surname>Huber</surname><given-names>W.</given-names></name><name><surname>Anders</surname><given-names>S.</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DEseq2</article-title><source>Genome Biol.</source><volume>15</volume><year>2014</year><fpage>550</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Lee-Six</surname><given-names>H.</given-names></name><name><surname>Olafsson</surname><given-names>S.</given-names></name><name><surname>Ellis</surname><given-names>P.</given-names></name><name><surname>Osborne</surname><given-names>R.J.</given-names></name><name><surname>Sanders</surname><given-names>M.A.</given-names></name><name><surname>Moore</surname><given-names>L.</given-names></name><name><surname>Georgakopoulos</surname><given-names>N.</given-names></name><name><surname>Torrente</surname><given-names>F.</given-names></name><name><surname>Noorani</surname><given-names>A.</given-names></name><name><surname>Goddard</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The landscape of somatic mutation in normal colorectal epithelial cells</article-title><source>Nature</source><volume>574</volume><year>2019</year><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1672-7</pub-id><pub-id pub-id-type="pmid">31645730</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Mao</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wen</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis</article-title><source>Gut</source><volume>69</volume><year>2020</year><fpage>1283</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2019-319438</pub-id><pub-id pub-id-type="pmid">31744909</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Di</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A body map of somatic mutagenesis in morphologically normal human tissues</article-title><source>Nature</source><volume>597</volume><year>2021</year><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03836-1</pub-id><pub-id pub-id-type="pmid">34433965</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Luciani</surname><given-names>A.</given-names></name><name><surname>Kobeiter</surname><given-names>H.</given-names></name><name><surname>Maison</surname><given-names>P.</given-names></name><name><surname>Cherqui</surname><given-names>D.</given-names></name><name><surname>Zafrani</surname><given-names>E.S.</given-names></name><name><surname>Dhumeaux</surname><given-names>D.</given-names></name><name><surname>Mathieu</surname><given-names>D.</given-names></name></person-group><article-title>Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?</article-title><source>Gut</source><volume>50</volume><year>2002</year><fpage>877</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1136/gut.50.6.877</pub-id><pub-id pub-id-type="pmid">12010893</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Maillette De Buy Wenniger</surname><given-names>L.</given-names></name><name><surname>Terpstra</surname><given-names>V.</given-names></name><name><surname>Beuers</surname><given-names>U.</given-names></name></person-group><article-title>Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology</article-title><source>Dig. Surg.</source><volume>27</volume><year>2010</year><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1159/000268404</pub-id><pub-id pub-id-type="pmid">20357448</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>MacParland</surname><given-names>S.A.</given-names></name><name><surname>Liu</surname><given-names>J.C.</given-names></name><name><surname>Ma</surname><given-names>X.Z.</given-names></name><name><surname>Innes</surname><given-names>B.T.</given-names></name><name><surname>Bartczak</surname><given-names>A.M.</given-names></name><name><surname>Gage</surname><given-names>B.K.</given-names></name><name><surname>Manuel</surname><given-names>J.</given-names></name><name><surname>Khuu</surname><given-names>N.</given-names></name><name><surname>Echeverri</surname><given-names>J.</given-names></name><name><surname>Linares</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations</article-title><source>Nat. Commun.</source><volume>9</volume><year>2018</year><fpage>4383</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-06318-7</pub-id><pub-id pub-id-type="pmid">30348985</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Mehine</surname><given-names>M.</given-names></name><name><surname>Kaasinen</surname><given-names>E.</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>N.</given-names></name><name><surname>Katainen</surname><given-names>R.</given-names></name><name><surname>K&#x000e4;mpj&#x000e4;rvi</surname><given-names>K.</given-names></name><name><surname>Pitk&#x000e4;nen</surname><given-names>E.</given-names></name><name><surname>Heinonen</surname><given-names>H.R.</given-names></name><name><surname>B&#x000fc;tzow</surname><given-names>R.</given-names></name><name><surname>Kilpivaara</surname><given-names>O.</given-names></name><name><surname>Kuosmanen</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Characterization of uterine leiomyomas by whole-genome sequencing</article-title><source>N.&#x000a0;Engl. J. Med.</source><volume>369</volume><year>2013</year><fpage>43</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1302736</pub-id><pub-id pub-id-type="pmid">23738515</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Martincorena</surname><given-names>I.</given-names></name><name><surname>Roshan</surname><given-names>A.</given-names></name><name><surname>Gerstung</surname><given-names>M.</given-names></name><name><surname>Ellis</surname><given-names>P.</given-names></name><name><surname>Van Loo</surname><given-names>P.</given-names></name><name><surname>McLaren</surname><given-names>S.</given-names></name><name><surname>Wedge</surname><given-names>D.C.</given-names></name><name><surname>Fullam</surname><given-names>A.</given-names></name><name><surname>Alexandrov</surname><given-names>L.B.</given-names></name><name><surname>Tubio</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>High burden and pervasive positive selection of somatic mutations in normal human skin</article-title><source>Science</source><volume>348</volume><year>2015</year><fpage>880</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1126/science.aaa6806</pub-id><pub-id pub-id-type="pmid">25999502</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Martincorena</surname><given-names>I.</given-names></name><name><surname>Raine</surname><given-names>K.M.</given-names></name><name><surname>Gerstung</surname><given-names>M.</given-names></name><name><surname>Dawson</surname><given-names>K.J.</given-names></name><name><surname>Haase</surname><given-names>K.</given-names></name><name><surname>Van Loo</surname><given-names>P.</given-names></name><name><surname>Davies</surname><given-names>H.</given-names></name><name><surname>Stratton</surname><given-names>M.R.</given-names></name><name><surname>Campbell</surname><given-names>P.J.</given-names></name></person-group><article-title>Universal patterns of selection in cancer and somatic tissues</article-title><source>Cell</source><volume>171</volume><year>2017</year><fpage>1029</fpage><lpage>1041.e21</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.042</pub-id><pub-id pub-id-type="pmid">29056346</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Mayakonda</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>D.C.</given-names></name><name><surname>Assenov</surname><given-names>Y.</given-names></name><name><surname>Plass</surname><given-names>C.</given-names></name><name><surname>Koeffler</surname><given-names>H.P.</given-names></name></person-group><article-title>Maftools: efficient and comprehensive analysis of somatic variants in cancer</article-title><source>Genome Res.</source><volume>28</volume><year>2018</year><fpage>1747</fpage><lpage>1756</lpage><pub-id pub-id-type="doi">10.1101/gr.239244.118</pub-id><pub-id pub-id-type="pmid">30341162</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>Mootha</surname><given-names>V.K.</given-names></name><name><surname>Lindgren</surname><given-names>C.M.</given-names></name><name><surname>Eriksson</surname><given-names>K.F.</given-names></name><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Sihag</surname><given-names>S.</given-names></name><name><surname>Lehar</surname><given-names>J.</given-names></name><name><surname>Puigserver</surname><given-names>P.</given-names></name><name><surname>Carlsson</surname><given-names>E.</given-names></name><name><surname>Ridderstr&#x000e5;le</surname><given-names>M.</given-names></name><name><surname>Laurila</surname><given-names>E.</given-names></name><etal/></person-group><article-title>PGC-1&#x003b1;-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title><source>Nat. Genet.</source><volume>34</volume><year>2003</year><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/ng1180</pub-id><pub-id pub-id-type="pmid">12808457</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>A.M.</given-names></name><name><surname>Steen</surname><given-names>C.B.</given-names></name><name><surname>Liu</surname><given-names>C.L.</given-names></name><name><surname>Gentles</surname><given-names>A.J.</given-names></name><name><surname>Chaudhuri</surname><given-names>A.A.</given-names></name><name><surname>Scherer</surname><given-names>F.</given-names></name><name><surname>Khodadoust</surname><given-names>M.S.</given-names></name><name><surname>Esfahani</surname><given-names>M.S.</given-names></name><name><surname>Luca</surname><given-names>B.A.</given-names></name><name><surname>Steiner</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Determining cell type abundance and expression from bulk tissues with digital cytometry</article-title><source>Nat. Biotechnol.</source><volume>37</volume><year>2019</year><fpage>773</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0114-2</pub-id><pub-id pub-id-type="pmid">31061481</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Nahm</surname><given-names>C.B.</given-names></name><name><surname>Ng</surname><given-names>K.</given-names></name><name><surname>Lockie</surname><given-names>P.</given-names></name><name><surname>Samra</surname><given-names>J.S.</given-names></name><name><surname>Hugh</surname><given-names>T.J.</given-names></name></person-group><article-title>Focal nodular hyperplasia&#x02014;a review of myths and truths</article-title><source>J.&#x000a0;Gastrointest. Surg.</source><volume>15</volume><year>2011</year><fpage>2275</fpage><lpage>2283</lpage><pub-id pub-id-type="doi">10.1007/s11605-011-1680-x</pub-id><pub-id pub-id-type="pmid">21959783</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>Nishiwaki</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Iwaguro</surname><given-names>H.</given-names></name><name><surname>Masuda</surname><given-names>H.</given-names></name><name><surname>Nitta</surname><given-names>N.</given-names></name><name><surname>Asahara</surname><given-names>T.</given-names></name><name><surname>Isobe</surname><given-names>M.</given-names></name></person-group><article-title>Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><volume>27</volume><year>2007</year><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000254812.23238.2b</pub-id><pub-id pub-id-type="pmid">17170379</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Oranger</surname><given-names>A.</given-names></name><name><surname>Brunetti</surname><given-names>G.</given-names></name><name><surname>Colaianni</surname><given-names>G.</given-names></name><name><surname>Tamma</surname><given-names>R.</given-names></name><name><surname>Carbone</surname><given-names>C.</given-names></name><name><surname>Lippo</surname><given-names>L.</given-names></name><name><surname>Mori</surname><given-names>G.</given-names></name><name><surname>Pignataro</surname><given-names>P.</given-names></name><name><surname>Cirulli</surname><given-names>N.</given-names></name><name><surname>Zerlotin</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Sclerostin stimulates angiogenesis in human endothelial cells</article-title><source>Bone</source><volume>101</volume><year>2016</year><fpage>26</fpage><lpage>36</lpage></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Andrews</surname><given-names>N.P.</given-names></name><name><surname>Padder</surname><given-names>F.A.</given-names></name><name><surname>Husain</surname><given-names>M.</given-names></name><name><surname>Quyyumi</surname><given-names>A.A.</given-names></name></person-group><article-title>Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability</article-title><source>J.&#x000a0;Am. Coll. Cardiol.</source><volume>34</volume><year>1999</year><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">10440166</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Paradis</surname><given-names>V.</given-names></name><name><surname>Laurent</surname><given-names>A.</given-names></name><name><surname>Flejou</surname><given-names>J.F.</given-names></name><name><surname>Vidaud</surname><given-names>M.</given-names></name><name><surname>Bedossa</surname><given-names>P.</given-names></name></person-group><article-title>Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation</article-title><source>Hepatology</source><volume>26</volume><year>1997</year><fpage>891</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1002/hep.510260414</pub-id><pub-id pub-id-type="pmid">9328310</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Petsas</surname><given-names>T.</given-names></name><name><surname>Tsamandas</surname><given-names>A.</given-names></name><name><surname>Tsota</surname><given-names>I.</given-names></name><name><surname>Karavias</surname><given-names>D.</given-names></name><name><surname>Karatza</surname><given-names>C.</given-names></name><name><surname>Vassiliou</surname><given-names>V.</given-names></name><name><surname>Kardamakis</surname><given-names>D.</given-names></name></person-group><article-title>A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature</article-title><source>World J. Gastroenterol.</source><volume>12</volume><year>2006</year><fpage>6567</fpage><lpage>6571</lpage><pub-id pub-id-type="doi">10.3748/wjg.v12.i40.6567</pub-id><pub-id pub-id-type="pmid">17072995</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>L.X.</given-names></name><name><surname>Tang</surname><given-names>Z.Y.</given-names></name><name><surname>Sham</surname><given-names>J.S.</given-names></name><name><surname>Ma</surname><given-names>Z.C.</given-names></name><name><surname>Ye</surname><given-names>S.L.</given-names></name><name><surname>Zhou</surname><given-names>X.D.</given-names></name><name><surname>Wu</surname><given-names>Z.Q.</given-names></name><name><surname>Trent</surname><given-names>J.M.</given-names></name><name><surname>Guan</surname><given-names>X.Y.</given-names></name></person-group><article-title>The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma</article-title><source>Cancer Res.</source><volume>59</volume><year>1999</year><fpage>5662</fpage><lpage>5665</lpage><pub-id pub-id-type="pmid">10582679</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Robling</surname><given-names>A.G.</given-names></name><name><surname>Niziolek</surname><given-names>P.J.</given-names></name><name><surname>Baldridge</surname><given-names>L.A.</given-names></name><name><surname>Condon</surname><given-names>K.W.</given-names></name><name><surname>Allen</surname><given-names>M.R.</given-names></name><name><surname>Alam</surname><given-names>I.</given-names></name><name><surname>Mantila</surname><given-names>S.M.</given-names></name><name><surname>Gluhak-Heinrich</surname><given-names>J.</given-names></name><name><surname>Bellido</surname><given-names>T.M.</given-names></name><name><surname>Harris</surname><given-names>S.E.</given-names></name><name><surname>Turner</surname><given-names>C.H.</given-names></name></person-group><article-title>Mechanical stimulation of bone in&#x000a0;vivo reduces osteocyte expression of SOST/sclerostin</article-title><source>J.&#x000a0;Biol. Chem.</source><volume>283</volume><year>2008</year><fpage>5866</fpage><lpage>5875</lpage><pub-id pub-id-type="doi">10.1074/jbc.M705092200</pub-id><pub-id pub-id-type="pmid">18089564</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal" id="sref101"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>P.</given-names></name><name><surname>Dobie</surname><given-names>R.</given-names></name><name><surname>Wilson-Kanamori</surname><given-names>J.R.</given-names></name><name><surname>Dora</surname><given-names>E.F.</given-names></name><name><surname>Henderson</surname><given-names>B.E.P.</given-names></name><name><surname>Luu</surname><given-names>N.T.</given-names></name><name><surname>Portman</surname><given-names>J.R.</given-names></name><name><surname>Matchett</surname><given-names>K.P.</given-names></name><name><surname>Brice</surname><given-names>M.</given-names></name><name><surname>Marwick</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Resolving the fibrotic niche of human liver cirrhosis at single-cell level</article-title><source>Nature</source><volume>575</volume><year>2019</year><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1631-3</pub-id><pub-id pub-id-type="pmid">31597160</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Rebouissou</surname><given-names>S.</given-names></name><name><surname>Couchy</surname><given-names>G.</given-names></name><name><surname>Libbrecht</surname><given-names>L.</given-names></name><name><surname>Balabaud</surname><given-names>C.</given-names></name><name><surname>Imbeaud</surname><given-names>S.</given-names></name><name><surname>Auffray</surname><given-names>C.</given-names></name><name><surname>Roskams</surname><given-names>T.</given-names></name><name><surname>Bioulac-Sage</surname><given-names>P.</given-names></name><name><surname>Zucman-Rossi</surname><given-names>J.</given-names></name></person-group><article-title>The &#x003b2;-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules</article-title><source>J.&#x000a0;Hepatol.</source><volume>49</volume><year>2008</year><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2008.03.013</pub-id><pub-id pub-id-type="pmid">18466996</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>A.</given-names></name><name><surname>Bocklage</surname><given-names>T.</given-names></name><name><surname>Greenbaum</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Ness</surname><given-names>S.A.</given-names></name></person-group><article-title>Mutant-allele tumor heterogeneity scores correlate with risk of metastases in colon cancer</article-title><source>Clin. Colorectal Cancer</source><volume>16</volume><year>2017</year><fpage>e165</fpage><lpage>e170</lpage><pub-id pub-id-type="doi">10.1016/j.clcc.2016.11.004</pub-id><pub-id pub-id-type="pmid">28073683</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>M.D.</given-names></name><name><surname>McCarthy</surname><given-names>D.J.</given-names></name><name><surname>Smyth</surname><given-names>G.K.</given-names></name></person-group><article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><year>2009</year><fpage>1572</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq170</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>R.</given-names></name><name><surname>McGranahan</surname><given-names>N.</given-names></name><name><surname>Herrero</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>B.S.</given-names></name><name><surname>Swanton</surname><given-names>C.</given-names></name></person-group><article-title>Deconstructsigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution</article-title><source>Genome Biol.</source><volume>17</volume><year>2016</year><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s13059-016-0893-4</pub-id><pub-id pub-id-type="pmid">26899170</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal" id="sref99"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Seow</surname><given-names>J.J.W.</given-names></name><name><surname>Dutertre</surname><given-names>C.</given-names></name><name><surname>Pai</surname><given-names>R.</given-names></name><name><surname>Bl&#x000e9;riot</surname><given-names>C.</given-names></name><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>R.M.M.</given-names></name><name><surname>Singh</surname><given-names>G.S.N.</given-names></name><name><surname>Sudhagar</surname><given-names>S.</given-names></name><name><surname>Khalilnezhad</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma</article-title><source>Cell</source><volume>183</volume><year>2020</year><fpage>377</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.08.040</pub-id><pub-id pub-id-type="pmid">32976798</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Tano</surname><given-names>V.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Rong</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny</article-title><source>Gut</source><volume>71</volume><year>2021</year><fpage>1176</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2021-324339</pub-id><pub-id pub-id-type="pmid">34253573</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Weng</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>R.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name></person-group><article-title>Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma</article-title><source>J.&#x000a0;Gastroenterol. Hepatol.</source><volume>32</volume><year>2017</year><fpage>1107</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1111/jgh.13633</pub-id><pub-id pub-id-type="pmid">27806438</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T.</given-names></name><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Hoffman</surname><given-names>P.</given-names></name><name><surname>Hafemeister</surname><given-names>C.</given-names></name><name><surname>Papalexi</surname><given-names>E.</given-names></name><name><surname>Mauck</surname><given-names>W.M.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Stoeckius</surname><given-names>M.</given-names></name><name><surname>Smibert</surname><given-names>P.</given-names></name><name><surname>Satija</surname><given-names>R.</given-names></name></person-group><article-title>Comprehensive integration of Single-Cell data</article-title><source>Cell</source><volume>177</volume><year>2019</year><fpage>1888</fpage><lpage>1902.e21</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Tamayo</surname><given-names>P.</given-names></name><name><surname>Mootha</surname><given-names>V.K.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Ebert</surname><given-names>B.L.</given-names></name><name><surname>Gillette</surname><given-names>M.A.</given-names></name><name><surname>Paulovich</surname><given-names>A.</given-names></name><name><surname>Pomeroy</surname><given-names>S.L.</given-names></name><name><surname>Golub</surname><given-names>T.R.</given-names></name><name><surname>Lander</surname><given-names>E.S.</given-names></name><name><surname>Mesirov</surname><given-names>J.P.</given-names></name></person-group><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>102</volume><year>2005</year><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C.</given-names></name><name><surname>Cacchiarelli</surname><given-names>D.</given-names></name><name><surname>Grimsby</surname><given-names>J.</given-names></name><name><surname>Pokharel</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Morse</surname><given-names>M.</given-names></name><name><surname>Lennon</surname><given-names>N.J.</given-names></name><name><surname>Livak</surname><given-names>K.J.</given-names></name><name><surname>Mikkelsen</surname><given-names>T.S.</given-names></name><name><surname>Rinn</surname><given-names>J.L.</given-names></name></person-group><article-title>The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells</article-title><source>Nat. Biotechnol.</source><volume>32</volume><year>2014</year><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/nbt.2859</pub-id><pub-id pub-id-type="pmid">24658644</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Nakashima</surname><given-names>O.</given-names></name><name><surname>Wada</surname><given-names>Y.</given-names></name><name><surname>Kage</surname><given-names>M.</given-names></name><name><surname>Kojiro</surname><given-names>M.</given-names></name></person-group><article-title>Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver</article-title><source>Hepatology</source><volume>24</volume><year>1996</year><fpage>807</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1053/jhep.1996.v24.pm0008855180</pub-id><pub-id pub-id-type="pmid">8855180</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name><surname>Talevich</surname><given-names>E.</given-names></name><name><surname>Shain</surname><given-names>A.H.</given-names></name><name><surname>Botton</surname><given-names>T.</given-names></name><name><surname>Bastian</surname><given-names>B.C.</given-names></name></person-group><article-title>CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing</article-title><source>PLoS Comput. Biol.</source><volume>12</volume><year>2016</year><object-id pub-id-type="publisher-id">e1004873</object-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004873</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name><surname>Tajiri</surname><given-names>K.</given-names></name><name><surname>Tsuneyama</surname><given-names>K.</given-names></name><name><surname>Kawai</surname><given-names>K.</given-names></name><name><surname>Atarashi</surname><given-names>Y.</given-names></name><name><surname>Minemura</surname><given-names>M.</given-names></name><name><surname>Sawada</surname><given-names>S.</given-names></name><name><surname>Tsukada</surname><given-names>K.</given-names></name><name><surname>Imura</surname><given-names>J.</given-names></name><name><surname>Sugiyama</surname><given-names>T.</given-names></name></person-group><article-title>A case of progressing focal nodular hyperplasia and its molecular expression pattern</article-title><source>Clin. J. Gastroenterol.</source><volume>7</volume><year>2014</year><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1007/s12328-014-0483-5</pub-id><pub-id pub-id-type="pmid">26183749</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>V.H.</given-names></name><name><surname>Pipinikas</surname><given-names>C.P.</given-names></name><name><surname>Pennycuick</surname><given-names>A.</given-names></name><name><surname>Lee-Six</surname><given-names>H.</given-names></name><name><surname>Chandrasekharan</surname><given-names>D.</given-names></name><name><surname>Beane</surname><given-names>J.</given-names></name><name><surname>Morris</surname><given-names>T.J.</given-names></name><name><surname>Karpathakis</surname><given-names>A.</given-names></name><name><surname>Feber</surname><given-names>A.</given-names></name><name><surname>Breeze</surname><given-names>C.E.</given-names></name><etal/></person-group><article-title>Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions</article-title><source>Nat. Med.</source><volume>25</volume><year>2019</year><fpage>517</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0323-0</pub-id><pub-id pub-id-type="pmid">30664780</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name><surname>Torri</surname><given-names>G.B.</given-names></name><name><surname>Soldatelli</surname><given-names>M.D.</given-names></name><name><surname>Luersen</surname><given-names>G.F.</given-names></name><name><surname>Almeida Ghezzi</surname><given-names>C.L.</given-names></name></person-group><article-title>Imaging of chemotherapy-induced liver toxicity: an illustrated overview</article-title><source>Hepat. Oncol.</source><volume>8</volume><year>2021</year><fpage>HEP32</fpage><pub-id pub-id-type="doi">10.2217/hep-2020-0026</pub-id><pub-id pub-id-type="pmid">34765105</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name><surname>Tomasetti</surname><given-names>C.</given-names></name></person-group><article-title>Mutated clones are the new normal</article-title><source>Science</source><volume>364</volume><year>2019</year><fpage>938</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1126/science.aax5525</pub-id><pub-id pub-id-type="pmid">31171683</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal" id="sref100"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C.</given-names></name><name><surname>Roberts</surname><given-names>A.</given-names></name><name><surname>Goff</surname><given-names>L.</given-names></name><name><surname>Pertea</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Kelley</surname><given-names>D.R.</given-names></name><name><surname>Pimentel</surname><given-names>H.</given-names></name><name><surname>Salzberg</surname><given-names>S.L.</given-names></name><name><surname>Rinn</surname><given-names>J.L.</given-names></name><name><surname>Pachter</surname><given-names>L.</given-names></name></person-group><article-title>Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks</article-title><source>Nat Protoc</source><volume>7</volume><year>2012</year><fpage>562</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.016</pub-id><pub-id pub-id-type="pmid">22383036</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Hakonarson</surname><given-names>H.</given-names></name></person-group><article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title><source>Nucleic Acids Res.</source><volume>38</volume><year>2010</year><fpage>e164</fpage><pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id><pub-id pub-id-type="pmid">20601685</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name><surname>Wilkerson</surname><given-names>M.D.</given-names></name><name><surname>Ayes</surname><given-names>D.N.H.</given-names></name></person-group><article-title>Consensusclusterplus: a class discovery tool with confidence assessments and item tracking</article-title><source>Bioinformatics</source><volume>26</volume><year>2010</year><fpage>1572</fpage><lpage>1573</lpage><pub-id pub-id-type="pmid">20427518</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name><surname>Wijewardhane</surname><given-names>N.</given-names></name><name><surname>Dressler</surname><given-names>L.</given-names></name><name><surname>Ciccarelli</surname><given-names>F.D.</given-names></name></person-group><article-title>Normal somatic mutations in cancer transformation</article-title><source>Cancer Cell</source><volume>39</volume><year>2021</year><fpage>125</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2020.11.002</pub-id><pub-id pub-id-type="pmid">33220180</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H.</given-names></name></person-group><article-title>ggplot2</article-title><source>WIREs. Comp. Stat.</source><volume>3</volume><year>2011</year><fpage>180</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1002/wics.147</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>R.G.</given-names></name><name><surname>Kruglov</surname><given-names>E.</given-names></name><name><surname>Dranoff</surname><given-names>J.A.</given-names></name></person-group><article-title>Autocrine release of TGF-&#x003b2; by portal fibroblasts regulates cell growth</article-title><source>FEBS Lett.</source><volume>559</volume><year>2004</year><fpage>107</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(04)00037-7</pub-id><pub-id pub-id-type="pmid">14960316</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name><surname>Yasui</surname><given-names>K.</given-names></name><name><surname>Arii</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Imoto</surname><given-names>I.</given-names></name><name><surname>Ueda</surname><given-names>M.</given-names></name><name><surname>Nagai</surname><given-names>H.</given-names></name><name><surname>Emi</surname><given-names>M.</given-names></name><name><surname>Inazawa</surname><given-names>J.</given-names></name></person-group><article-title>TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas</article-title><source>Hepatology</source><volume>35</volume><year>2002</year><fpage>1476</fpage><lpage>1484</lpage><pub-id pub-id-type="doi">10.1053/jhep.2002.33683</pub-id><pub-id pub-id-type="pmid">12029633</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L.G.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>Q.Y.</given-names></name></person-group><article-title>Clusterprofiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS</source><volume>16</volume><year>2012</year><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Song</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>Q.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Newly detected liver nodules with a history of colorectal cancer: are they metastatic? Review of 2, 632 cases in a single center</article-title><source>Ann. Transl. Med.</source><volume>9</volume><year>2021</year><fpage>1079</fpage><pub-id pub-id-type="doi">10.21037/atm-20-8153</pub-id><pub-id pub-id-type="pmid">34422991</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>T.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Gopal</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Odewole</surname><given-names>M.</given-names></name><name><surname>Renteria</surname><given-names>V.</given-names></name><name><surname>Singal</surname><given-names>A.G.</given-names></name><name><surname>Jang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease</article-title><source>Cell</source><volume>177</volume><year>2019</year><fpage>608</fpage><lpage>621.e12</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.03.026</pub-id><pub-id pub-id-type="pmid">30955891</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name><surname>Zekri</surname><given-names>A.R.N.</given-names></name><name><surname>Sabry</surname><given-names>G.M.</given-names></name><name><surname>Bahnassy</surname><given-names>A.A.</given-names></name><name><surname>Shalaby</surname><given-names>K.A.</given-names></name><name><surname>Abdel-Wahabh</surname><given-names>S.A.</given-names></name><name><surname>Zakaria</surname><given-names>S.</given-names></name></person-group><article-title>Mismatch repair genes (HMLH1, HPMS1, HPMS2, GTBP/HMSH6, HMSH2) in the pathogenesis of hepatocellular carcinoma</article-title><source>World J. Gastroenterol.</source><volume>11</volume><year>2005</year><fpage>3020</fpage><lpage>3026</lpage><pub-id pub-id-type="doi">10.3748/wjg.v11.i20.3020</pub-id><pub-id pub-id-type="pmid">15918183</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name><surname>Ziche</surname><given-names>M.</given-names></name><name><surname>Morbidelli</surname><given-names>L.</given-names></name><name><surname>Donnini</surname><given-names>S.</given-names></name><name><surname>Ledda</surname><given-names>F.</given-names></name></person-group><article-title>ETB receptors promote proliferation and migration of endothelial cells</article-title><source>J.&#x000a0;Cardiovasc. Pharmacol.</source><volume>26</volume><year>1995</year><fpage>S284</fpage><lpage>S286</lpage><pub-id pub-id-type="doi">10.1097/00005344-199506263-00085</pub-id><pub-id pub-id-type="pmid">8587389</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal" id="sref98"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ge</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Shi</surname><given-names>G.</given-names></name></person-group><article-title>Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma</article-title><source>J. Hepatol.</source><volume>73</volume><year>2020</year><fpage>1118</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2020.05.039</pub-id><pub-id pub-id-type="pmid">32505533</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal" id="sref96"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.Z.</given-names></name><name><surname>Venardos</surname><given-names>K.</given-names></name><name><surname>Chin-Dusting</surname><given-names>J.</given-names></name><name><surname>Kaye</surname><given-names>D.M.</given-names></name></person-group><article-title>Adverse effects of cigarette smoke on no bioavailability</article-title><source>Hypertension</source><volume>48</volume><year>2006</year><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000231509.27406.42</pub-id><pub-id pub-id-type="pmid">16801489</pub-id></element-citation></ref></ref-list><sec id="appsec2" sec-type="supplementary-material"><title>Supplemental information</title><p id="p0415">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Figures&#x000a0;S1&#x02013;S7</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc2"><caption><title>Table&#x000a0;S1. Clinical information of 22 FNH patients, related to Figures&#x000a0;1&#x02013;6</title></caption><media xlink:href="mmc2.xlsx"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc3"><caption><title>Table&#x000a0;S2. Somatic mutations of 19 FNH samples, related to Figure&#x000a0;1</title></caption><media xlink:href="mmc3.xlsx"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc4"><caption><title>Table&#x000a0;S3. Information for Sanger sequencing validation, related to Figure&#x000a0;1</title></caption><media xlink:href="mmc4.xlsx"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc5"><caption><title>Table&#x000a0;S4. GSEA of IC7 based on xCell 64 cell types, related to Figures&#x000a0;2 and 3</title></caption><media xlink:href="mmc5.xlsx"/></supplementary-material>
</p></sec><sec sec-type="data-availability" id="da0010"><title>Data and code availability</title><p id="p0025">All sequencing raw data, including WES, RNA-seq and scRNA-seq, are deposited in NODE (<ext-link ext-link-type="uri" xlink:href="https://www.biosino.org/node" id="intref0010">https://www.biosino.org/node</ext-link>) under the accession number OEP002718. This paper does not report original code. Any additional information required to reanalyze the data reported in this work paper is available from the <xref rid="sec4.2.1" ref-type="sec">lead contact</xref> upon request.</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0395">We thank Dr. Yumeng Sun and Dr. Lu Meng, from Institute Pasteur of Shanghai, Chinese Academy of Sciences for technical assistance. We thank Ms. Yifei Cheng from Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital for the important support of written English. We thank all members of the laboratory for their insightful discussions. We would also like to acknowledge the funding of the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> (Nos. 81961128025, 82121002, 32070679, U1804284, 81871055), <funding-source id="gs2">Program of Shanghai Academic Research</funding-source> Leader (No. 19XD1420700), the <funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100012166</institution-id><institution>National Key R&#x00026;D Program of China</institution></institution-wrap></funding-source> (2021YFC2702100, 2019YFA0905400, 2017YFC0908105), <funding-source id="gs4">Shanghai Municipal Science and Technology</funding-source> Major Project (2017SHZDZX01), <funding-source id="gs5">Taishan Scholar Program of Shandong Province</funding-source> (tsqn201812153), <funding-source id="gs6"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100007129</institution-id><institution>Natural Science Foundation of Shandong Province</institution></institution-wrap></funding-source> (ZR2019YQ14) and <funding-source id="gs7">Zhupei Foundation of Zhongshan Hospital</funding-source> (Zhupei 2021-001).</p><sec id="sec5"><title>Author contributions</title><p id="p0400">Q.G. and Y-Y.S. conceived and directed the project. Y-M.L., L-Q.D., and D-N.R. collected surgical samples and clinical data. J-M.Z., K.W., and Y-M.L. wrote the code for analysis and Y-C.W. and Q.G. were responsible for verification. J-Q.M. designed immunohistochemistry panel. Y-M.L. performed experiments and M.Z., Y-P.L., and Z-J.Y. provided experimental support. J.F. and Z-B.D. provided important intellectual input. Y-M.L. and J-M.Z. wrote the manuscript with the assistance of Z.W. and X-M.Z. All authors critically revised the manuscript.</p></sec><sec sec-type="COI-statement" id="sec6"><title>Declaration of interests</title><p id="p0405">The authors declare no competing interests.</p></sec></ack><fn-group><fn id="appsec1" fn-type="supplementary-material"><p id="p0410">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.isci.2022.104921" id="intref0230">https://doi.org/10.1016/j.isci.2022.104921</ext-link>.</p></fn></fn-group></back></article>
